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CHAPTER 1 
GENERAL INTRODUCTION 

INTRODUCTION 
Malaria continues to be the most important parasitic disease in the tropics, causing 
considerable morbidity and mortality - especially in childhood in areas with continuous 
transmission -, 
Four different species of human parasites causing malaria are known: Plasmodium vivax, 
Plasmodium ovale, Plasmodium malariae and Plasmodium falciparum, last species being 
lethal. The reservoir of the causitive organisms is in the infected human, and transmission 
of the parasite is via the bite of infected female anopheline mosquitoes. 
The parasites have resisted, most effectively, all strategies employed to control it, including 
a variety of drugs and various experimental immunological efforts. Also the mosquito vector 
matches control by developing high levels of physiologic insecticide resistance or a change 
in biting behaviour in order to evade wall surfaces sprayed with insecticides and impregnated 
bednets. 
The aim of this study has been to extend the knowledge on the biochemistry of the 
human malaria parasite P.falciparum, in particular during the sexual stage, as a contribution 
to malaria vaccin development. In this thesis, results are reported of the isolation and 
characterization of two proteins present in the sexual stage of Plasmodium falciparum. 
BIOLOGY OF THE SEXUAL STAGE 
The sexual stages in the life cycle of Plasmodium accomplish the transmission of the 
parasite from the vertebrate host to the anopheline vector. The gametocyte is the first 
morphologically and physiologically distinct form of the sexual stage (Fig. 1) and develops 
following invasion of a red blood cell by a merozoite. The mechanism for the induction of 
gametocytogenesis (the differentiation of a merozoite into a sexual parasite) is as yet not 
known (1,2). Investigations on this subject have shown only that individual schizonts are 
almost fully committed to produce exclusively either gametocytes or asexual parasites (3,4). 
Furthermore, it appears that the degree of commitment to sexual or asexual development 
represents an intrinsic biological property of P.falciparum schizonts (3). Maturation of the 
gametocytes occurs intracellularly and requires 7-12 days to reach morphological and 
functional maturity (1,2,5,6). The mature and functional gametocytes, which are ingested by 
an appropriate anopheles species during a bloodmeal (Fig. 1), are stimulated to transform 
into gametes under the influence of changes in temperature and (^-pressure (1,7-9). The 
transformation of the gametocyte comprises two different phases, (i) The gametocyte 
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Figure 1. The development of sexual stage malaria parasites of the human malaria parasite Plasmodium falciparum. 
Approximate duration of the event mdicated after the mvasion of a merozoite in a red blood cell. 
~ Approximate duration of the events mdicated after ingestion of mature micro- and macrogametocytes by a mosquito. The values vary according to 
temperature and other factors. 
becomes extracellular, probably mediated by the release of a parasite originated proteins 
(enzymes?) which disrupt the surrounding host cell membrane (1,10). (ii) The 
microgametocyte (male form) duplicates its DNA, several times within 3 minutes, and forms 
eight highly motile microgametes (11). At the same time, the macrogametocyte increases the 
cell volume and 'rounds up' (1,12). Fertilization of the macrogametes ensues (Fig. 1), and 
is complete within 10-30 minutes after ingestion of a blood meal (1,7,12). During the 16-20 
hours following fertilization each zygote transforms into an ookinete (Fig. 1). The motile 
ookinete crosses the mosquito midgut and continues its development on the outer side of the 
midgut adjacent to the haemocoel (Fig. 1), with the formation of the asexual sporozoites. 
BIOCHEMICAL ASPECTS OF THE SEXUAL STAGES 
During development and maturation, the sexual stages pass through a sequence of 
biochemical changes. 
DNA/RNA synthesis: The process of DNA synthesis has been studied for the species 
P.berghei, P.yoelii nigeriensis (both non-human species) and P.falciparum. In first instance, 
the process of DNA synthesis has been studied using mitomycin-C, an inhibitor of DNA 
synthesis, and it was assumed that the mature macrogametocytes were diploid and the mature 
microgametocytes were octoploid (13,14). DNA synthesis in malaria parasites, however, has 
shown to be highly insensitive to mitomycin-C (15). Eventually, measurements of the DNA 
content by direct microfluorometry and flow cytometry revealed that the intra-erythrocytic 
micro- and macrogametocytes synthesize DNA only during the transformations of ringforms 
into stage I gametocytes (11). The mature male and female gametocyte contain about twice 
the amount of DNA of the haploid ringstages. After activation, the microgametocytes 
duplicate their genome several times, while the DNA content of the macrogametes remains 
constant during gametogenesis (11). Following fertilization, the DNA content reaches 
approximately the tetraploid value (16). The time of DNA synthesis coincides with the time 
of meiosis, which strongly suggests that the DNA synthesis represents the genome duplication 
of the first meiotic division (16). It seems, therefore that Plasmodium follows the normal 
eukaryotic pattern, and normal patterns of recombinations of genes may be expected. 
Even less is known about the RNA transcription, processing and degradation in the sexual 
stages. Inhibition of the DNA-directed RNA synthesis by actinomycin D suggests that the 
rate of RNA synthesis reduces with increasing maturity of the gametocytes (14). Other 
experiments with actinomycin D also indicate that protein synthesis during gametogenesis 
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might require the de novo synthesis of mRNA (13,17). However it cannot be excluded that 
long-lived mRNA, presynthesized in the maturing gametocyte, is translated on stage-specific 
ribosomes (18,19). 
Protein synthesis: The dynamics of protein synthesis during gametocytogenesis has 
been studied using the metabolic inhibitors emetine, puromycine and cycloheximide (13,14). 
During the first part of gametocytogenesis the de novo protein synthesis takes place normally, 
but during the last period of maturation the gametocytes showed a marked reduction in 
protein synthesis (1,14). This reduction is most probably related to the reduction in the rate 
of mRNA synthesis. Induction of gametogenesis initiates the¿e novo protein synthesis, which 
is essential during exflagellation (13,17). Between 30 and 40 minutes after the induction of 
gametogenesis, the de novo protein synthesis in P.falcipanm reaches a certain rate which 
remains constant for at least five hours (17). Protein synthesis seems to take place normally, 
but very little is known about the dynamics of protein synthesis in the subsequent stages 
(retort cell, ookinete) of the sexual stage. 
SPECIFIC ANTIGENS OF THE SEXUAL STAGES 
Identification of stage-specific antigens 
P.gallinaceum and P.falcipanm sexual stages have been the most important species 
for the identification of stage-specific antigens. The main interest was directed towards the 
surface of the extracellular gametes, zygotes and ookinetes. The techniques of surface 
labelling of proteins (radio-iodination) and specific immune sera were used for the 
identification of stage specific antigens. Therefore, the identified antigens of gametes, zygotes 
and ookinetes are mainly surface proteins. 
Eighteen proteins, expressed on the surface of female gametes of P.gallinaceum, have been 
identified by radio-iodination and immunoprecipitation (20,21). The apparent molecular 
weights range from 17 to 230 kiloDalton (kDa) on SDS-PAGE under non-reducing 
conditions. The most immunogenic proteins among these labelled proteins have molecular 
masses of 230, 210, 48, 45, 40, 20 and 18-kDa and the 230-kDa, 48-kDa and 45-kDa 
proteins occur in an apparently identical form on the surface of female and male gametes 
(21). The gamete surface proteins appear to be specific for the sexual stages and do not react 
by immuno-competition with antigens of asexual blood stage parasites (21). 
Using monoclonal antibodies directed against proteins of gametocytes and gametes of 
P.falcipanm, a set of three proteins, with a molecular weight of 230-kDa, 48-kDa and 45-
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kDa, has been identified on the surface of gametes of P.falciparum (22,23). Each of these 
three proteins was differently immunoprecipitated using different antibodies (as will be 
discussed later), whereby the 230-kDa antigen turned out to coprecipitate mainly aspecifically 
and the 48-kDa and 45-kDa antigens showed to be antigenically related (23). A protein of 
about 16-kDa was also identified on female gametes of P.falciparum, since the protein 
showed an antigenic cross-reaction with the 45-kDa protein. The three proteins, 230-kDa, 
48-kDa and 45-kDa on SDS-PAGE under non-reducing conditions, are homologous to the 
230-kDa, 48-kDa and 45-kDa proteins which are described above for P.gallinacewn. Proteins 
corresponding to the 48-kDa and 45-kDa proteins of P.falciparum and P.gallinacewn have 
been described for other species: in P. vivax two proteins of 42-kDa and 36-kDa (24) and in 
P.yoelii nigeriensis a 42-kDa protein (25). 
Indirect immunofluorescence using a stage-specific monoclonal antibody identified another 
abundant stage-specific antigen in P.falciparum. However, this protein, which exists in two 
apparent molecular weight sizes of 25-kDa and 27-kDa, is not present on the surface of the 
sexual stages but only intracellularly in the gametocytes (26). 
The overall protein composition of the zygote surface membrane is essentially the 
same as that of the female gamete (23). The protein composition of the surface changes, 
during the transformation of a zygote into a ookinete (27). During this process, proteins in 
the Mr range between 45-kDa and 230-kDa are shed from the surface and new proteins 
appear (27). In case of P.gallinacewn two different proteins, a 31-kDa and 34-kDa protein, 
appear on the surface of the transforming zygote; the 31-kDa protein appears at about 3-4 
hours and the 34-kDa protein at 6-8 hours post-gametogenesis. The corresponding protein 
in P.falciparum is a 25-kDa protein (23), which appears at least at about 30-40 minutes post-
gametogenesis on the surface of the transforming zygote (Vermeulen et al. unpublished 
results). In P.berghei a similar protein has been identified with a molecular mass of 21-kDa 
(28). 
Biosynthesis of the stage-specific antigens 
The biosynthesis of the identified stage-specific proteins have been studied in both 
P.falciparum and P.gallinacewn principally by metabolic labelling ("S-methionine). 
The 27/25-kDa protein, abundantly present in the gametocytes but not expressed on the 
surface of gametes, is synthesized beginning at 30 to 40 hours after merozoite invasion 
onwards and continues throughout the subsequent development of the gametocytes (26). The 
230-kDa, 48-kDa and 45-kDa proteins, present on the gamete surface, are also synthesized 
by an early developmental stage in the gametocytes of P.falciparum (29,30). None of these 
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proteins are synthesized by asexual blood parasites or by the gametes and the subsequent 
sexual stages. Furthermore they are synthesized simultaneously and no precursor-product 
relationship has been defined between them; neither between the 230-kDa protein and the 
48/45-kDa proteins, nor between the 48-kDa and the 45-kDa protein. In P.falciparum and 
in P.gallinaceum a higher molecular weight protein (240-kDa and 280/300-kDa, respectively) 
has been identified by monoclonal antibodies (29,24). In both cases the relationship between 
the 230-kDa protein and the antigenically related protein of higher molecular weight is not 
fully understood. The higher molecular weight protein is probably an intracellular precursor 
molecule; however, no evidence supports this assumption. 
The biosynthesis of the major zygote and ookinete surface protein (25-kDa) of 
P.falciparum begins as early as day 3 of gametocyte development at a very low level (29). 
However, immediately after the induction of gametogenesis the de novo synthesis of the 25-
kDa protein is initiated and occurs throughout the developmental stages (17). In the motile 
ookinete stage, the 25-kDa protein is shed during movement of the ookinete (31; Fries 
unpublished results). Therefore, the protein needs to be synthesized continuously in order to 
replenish the surface of the ookinete. 
The corresponding 31-kDa and 34-kDa proteins of P.gallinaceum are not synthesized during 
gametocytogenesis, but only after initiation of gametogenesis (32), whereby the time point 
for the actual beginning of the de novo synthesis is not known. The synthesis of these 
proteins does not occur simultaneously; two hours after induction of gametogenesis only the 
31-kDa protein is synthesized. Between five and six hours post-gametogenesis the 
transforming zygote starts to synthesize the 34-kDa protein. The 34-kDa protein is then, 
twenty-two hours post-gametogenesis, the predominantly synthesized protein. It seems that 
the synthesis of these proteins is regulated during the development of the zygote into an 
ookinete (32). Furthermore, the controlling elements probably act at a post-transcriptional 
level since messages for both proteins of P.gallinaceum already exist in similar amounts in 
the newly fertilized zygotes (24). 
The similar 21-kDa protein of P.berghei is also synthesized only after initiation of 
gametogenesis and appears within two hours after exflagellation/fertilization on the parasite 
surface (28). 
Physical and chemical properties of the 230-kDa, 48-kDa, 45-kDa and 25-kDa antigens 
of P.falciparum and P.gallinaceum 
After their synthesis, proteins can be modified in several ways. The post-translational 
glycosylation, acylation and the formation of disulphide linkages are the most important 
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modifications which have been investigated. The 230-kDa protein of P.falciparum is not 
modified by glycosyl or acyl groups (29,30). The shift of molecular weight to 260-kDa in 
P.falciparum and to 240-kDa in P.gallinaceum on SDS-PAGE under reducing conditions 
(21,23) indicates that disulphide linkages are present in the native protein. 
The 48-kDa and 45-kDa antigens, which are antigenically related, are both 
glycoproteins (29,30) but are not modified by acyl groups. Under reducing conditions the Mr 
of the 48-kDa and 45-kDa proteins shift to 59-kDa and 53-kDa respectively in P.falciparum 
and to 56-kDa and 54-kDa in P.gallinaceum (21,23,30), indicating that disulphide linkages 
are present in these proteins as well. It also indicates that no disulphide linkages exist 
between the two proteins. Besides the similarities in the post-translational modifications of 
the 48-kDa and 45-kDa proteins, they also possess the same iso-electric point, i.e. 6.0 ± 0.1 
(29). As yet the only difference observed between these two proteins is their molecular 
weight, which has thus far been attributed to non-charged components such as a signal 
peptide or a difference in the bound carbohydrate groups. 
The set of three proteins (230-kDa, 48-kDa and 45-kDa) of P.falciparum, as well as 
those of P.gallinaceum, is physically closely associated in the parasite membrane. They can 
be immunoprecipitated as a complex by a monoclonal antibody directed against only one 
member of the complex (33,34), although they do not share antigenic determinants. 
However, the individual proteins can also be immunoprecipitated as a single protein 
(23,33,34), indicating that the proteins are also present in an uncomplexed form. The 
physically associated complex can be divided into two components with distinct hydrophobic 
properties. The 48-kDa and 45-kDa proteins are highly hydrophobic, while the 230-kDa 
protein is hydrophilic, or relatively much less hydrophobic, as extraction in Triton X-114 
revealed (33). This suggests that the 48-kDa and 45-kDa proteins may be integral membrane 
proteins while the 230-kDa protein is more likely to be a peripheral membrane protein. The 
interaction between the 230-kDa protein and the 48-kDa and 45-kDa proteins is most 
probably hydrophobic in nature and thus very strong and stable. 
The 25-kDa protein of P.falciparum and the 31-kDa and the 34-kDa proteins of 
P.gallinaceum are similarly post-translationally modified by glycosylation and acylation 
(29,32). In both species, glycosylation could be demonstrated by labelling the proteins with 
3H-mannose and 3H-glucosamine. The function of these glycosyl groups and the nature of the 
linkages between the glycosyl groups (O-glycosylated and/or N-glycosylated) and the protein 
has not yet been investigated. Acylation was demonstrated by labelling the proteins with 3H-
palmitate and 3H-myristate (32,35). The acylation of proteins may play a role in facilitating 
lipid bilayer interaction or has a function in membrane fusion events (36). This may also be 
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the function of acylation of the 25-kDa protein. However, investigations on these possible 
functions have not been published yet. The nature of the linkage of the fatty acids to the 
protein is suggested to be a glycosyl-phosphatidyl-inositol bond (3 8). This type of linkage has 
been described for several proteins, including two P.falciparum proteins (37). The suggestion 
for this type of linkage is based on the deduced amino acid sequence of the 25 kda protein 
(38), and strengthened by the fact that a glycosyl-phosphatidylinositol specific phospholipase 
С activity (GPI-PLC) is highly expressed in the sexual stages oí P.falciparum (39). However, 
evidence for this type of linkage based on the release of the 25-kDa protein by GPI-PLC, and 
on the chemical analysis of the membrane anchoring domain has not yet been established. 
Therefore, it can not precluded that the fatty acids are covalently bound via ester or thio-ester 
bonds to the protein. 
These proteins (25-kDa, 31-kDa and 34-kDa) are also very hydrophobic since they partition 
almost completely in the detergent phase of Triton X-114 (33,Ch.5). A striking feature of 
the 25-kDa protein is the very high cysteine content, being first indicated by biosynthetic 
labelling and the observed dependence of the correct folding of the protein on the presence 
of the original disulphide linkages (35). This was later confirmed by the deduction of the 
amino acid sequence from the DNA-sequence, whereby the amino acid composition revealed 
the presence of 11% cysteine (38). 
One striking difference between the 25-kDa protein of P.falciparum and the 31-kDa and the 
34-kDa protein of P.gallinaceum is the susceptibility for surface iodination. Before the amino 
acid sequence of the 25-kDa protein was known, it was suggested that this protein could not 
be labelled by surface iodination, due to the absence of tyrosine or histidine residues on the 
surface (23,29). The deduced amino acid sequence revealed the presence of five tyrosines 
and one histidine. It is however not clear where these residues are located in the native 
protein since the three-dimensional structure of the protein is not yet determined. 
The biological function of the described proteins is still not known. It is assumed that 
the 230-kDa, 48-kDa and 45-kDa proteins are involved in the process of fertilization, since 
antibodies directed against these antigens block further development of the parasite (22,23). 
The functional significance of the physically associated complex in the parasite membrane 
is also not known. 
A possible role for the 25-kDa protein may be the involvement in the movement of the 
ookinete and the penetration of the ookinete through the mosquito midgut wall. Antibodies 
directed against the 25-kDa protein interfere with ookinete maturation and oocyst formation 
(23). However, no direct evidence is available for the specific role of this protein in either 
of these processes. 
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IMMUNITY TO THE SEXUAL STAGES 
The sexual stages of the malaria parasite transmit the parasite from the vertebrate host 
to the mosquito vector. Immune reactions against these stages will tend to reduce the 
infectivity of the parasite to mosquitoes, and is therefore called transmission-blocking 
immunity. Two main effector mechanisms are involved in transmission-blocking immunity. 
During gametocyte development (in the blood circulation) and during the development of 
gametes into mature ookinetes in the mosquito midgut, the parasites can be attacked by these 
effector mechanisms; Both, the cell-mediated and the antibody-mediated immunity will be 
discussed. 
Cell-mediated immunity: Cell-mediated immunity has been shown to be effective in 
P.yoelii nigeriensis (40). Mice immunized with microgametes contained Τ cells which could 
block transmission of malaria to the mosquito in the absence of antibodies. The gamete-
specific Τ cell-mediated component of immunity appeared to reduce the numbers of 
circulating gametocytes in the blood stream (40). The antigens responsible for the stimulation 
of these transmission blocking Τ cells are unknown. 
Recent investigations on cell-mediated immunity towards the sexual stages of P.falciparum 
showed that gamete-reactive Τ cells are frequently present in peripheral blood from donors 
which had no history of clinical malaria (41). This suggests that, in the gamete organism, a 
large number of antigens and Τ cell epitopes can be expected. However, immunizations of 
different strains of H-2 congenie mice with purified gametes/zygotes oí P.falciparum showed 
that most mice strains were nonresponsive to two of the most important target antigens of 
transmission blocking antibodies (42). This restricted immune response is probably due to 
a limited number of Τ helper epitopes on these antigens (42). Also, a restricted immune 
response to these antigens has been observed in humans (43,44). Despite this often observed 
restriction in the immune response, an effective cellular immunity may well be induced since 
human Τ cells that react with gametes are frequently present in human blood (41). 
Antibody-mediated immunity: Antibody-mediated immunity was originally observed 
following artificial immunization with preparations containing sexual stages of malaria 
parasites (45-52). Serum samples of immunized animals were tested in a transmission 
blocking assay on the infectivity of the malaria sexual stage parasites (for a description of 
the transmission blocking assay, see ref. 23). A highly effective transmission-blocking 
immunity could be induced, in most instances with, little effect on the course of a parasitic 
infection following challenge (45-52). The experiments also showed that the sexual stages are 
very immunogenic and functionally independent from immunity against the asexual blood 
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Table 1. Interactions of transmission blocking mabs with the several target antigens. 
Target antigens 
P.falciparum 
P.gaUinaceum 
P.y.nigeriensis 
P.berghei 
(kDa) 
230 
48/45 
25 
230 
48/45 
31 
42 
21 
Mab 
28F1 
1B3 
2B4 
32F3 
32F1 
32F3 + 32F1 
IA3-B8 
1IC5-B10 
IA3-B8 + IIC5-B10 
32F61 
32F71 
ПОЗ 
ІАЗ-ВЗ 
ІШЗ + ІАЗ-ВЗ 
ІШ4 
IID2-C5I 
PYG.1 
12.1 
13.1 
TB-interaction type' 
1 2 3 
. 
- + 
- + 
+ 
. 
+ 
- + 
. 
+ ND + 
+ -
-
- + 
. 
+ -
- - -
+ -
blocks probably 
fertilization 
+ -
+ -
Ref. 
23 
55 
55 
23 
23 
23,59 
22 
22 
22,58 
23 
23 
53 
53 
53 
53 
53 
25 
28 
28 
ND = Not Done 
Interaction type 1: Blocks fertilization; type 2: Inhibit post-fertilization growth and development; 
type 3: Complement-dependent lysis of gametes/zygotes. 
parasites. Three different groups of antibodies were shown to be effective: (1) antibodies 
against gamete surface antigens which block parasite fertilization (45,46,48,51); (2) 
antibodies against ookinete surface antigens which inhibit post-fertilization growth and 
development (23,28,52); and (3) anti-gamete antibody, complement-dependent lysis of 
gametes and newly fertilized zygotes (22,51,52). 
The target antigens for the transmission blocking antibodies have been identified using 
monoclonal antibodies (mabs). The mabs identified a 230-kDa protein and a 48-kDa and 45-
kDa protein on the surface of gametes and newly fertilized zygotes of P.falciparum 
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(22,23,54,55), and a 25-kDa protein on the transforming zygotes and ookinetes (23). These 
target antigens for transmission blocking antibodies are comparable with proteins in other 
Plasmodium species (24,25,28,53;for review 56,57) as described above. The mabs which 
identified these target antigens, were tested on their transmission blocking capacity in an in-
vitro transmission-blocking assay (22,23,28,51-53), and some also by life feeds on passively 
immunized mice (25,28). The type of interaction of the mabs with their target antigens could 
also be assigned to one of the above described groups of antibodies. The transmission 
blocking capacity, the target antigens and the type of interaction of several mabs are 
summarized in Table 1. 
In both P.falcipanm and P.gallinaceum, the 230-kDa, 48-kDa and 45-kDa proteins 
are targets of transmission blocking mabs. Very little is known about the mabs and the 
epitopes on the 230-kDa protein. In P.falciparum, individual mabs directed against epitopes 
on the 230-kDa protein block the fertilization only in the presence of complement (55). 
However, in P.gallinaceum a reduced gametocyte infectivity was shown as a result of a 
synergistic effect of two distinct mabs in the absence of complement (53). The mechanisms 
by which the two mabs prevented the fertilization is not known. 
The immunological reactivity of the epitopes on the 48-kDa and 45-kDa proteins was 
investigated in more detail on Western blots and in a two-site radio-immuno assay. In 
P.falciparum the 48-kDa and 45-kDa protein were shown to be antigenically related, since 
different mabs (e.g. 32F1, 32F3) reacted with both proteins on ID and 2D Western blots 
(23,29). However, mabs recognize distinct epitopes on the target antigens as indicated by a 
difference in reactivity of the mabs on several isolates of P.falciparum (54). This observation 
was confirmed by experiments in a sandwich radio-immuno assay, where the antigen was 
bound by one mab (e.g. 32F1) and was still able to react with the other (e.g. 32F3) (58,59). 
Combinations of several mabs in these technique have defined at least four distinct epitopes 
on the 48-kDa and 45-kDa proteins (24,60). With the same technique, it was shown that the 
epitopes are monovalently expressed on the target antigens (58,59), in contrast to epitopes 
on proteins of other stages such as the circumsporozoite antigen in sporozoites (61). Mabs 
directed against the homologous proteins of P.gallinaceum and P.vivax reacted similarly 
(24,53). 
The nature of the epitopes on the 48-kDa and 45-kDa antigens has been investigated 
with regard to the contributions of the tertiary structure and the post-translational 
glycosylation. The immunological reactivity of the epitopes on the 48-kDa and 45-kDa 
proteins is most probably dependent on the tertiary structure of the protein, since none of the 
mabs react with the proteins after SDS-PAGE under reducing conditions (23). However, no 
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direct evidence could be obtained about the involvement of the disulphide linkages in the 
maintenance of the correct folding of the protein. The carbohydrate moieties, by which the 
proteins are post-translationally modified, could also contribute to the formation of the 
epitopes, or exist as an integral part of the epitope, as is shown for proteins of asexual stage 
parasites of P.falciparum (62). However, no direct evidence could be obtained for a 
contribution of the glycosyl groups to the epitopes on the 48-kDa and 45-lcDa proteins 
(Chapter 4). 
The major zygote/ookinete proteins of 25-kDa in P.falciparum, 31-kDa in 
P.gallinaceum and 21-kDa in P.berghei are also target antigens for transmission blocking 
mabs (23,28,63). The other corresponding protein (34-kDa) of P.gallinaceum is not a target 
of transmission blocking antibodies; several mabs directed against this protein had no effect 
on the infectivity of the gametocytes to the mosquito (63). On the 25-kDa protein of 
P.falciparum two distinct epitopes were identified with the two-site radio-immuno assay, 
which both are monovalently expressed (59). Only one epitope is involved in the transmission 
blocking immunity. 
The nature of these epitopes has also been investigated, and it was established that the 
tertiary structure of the protein was particularly important for the immunological reactivity 
of both epitopes (35). The high content of cysteines, indicating a high probability of internal 
disulphide linkages, is mainly responsible for this conclusion. The amino acid sequence 
deduced, following cloning of the gene for the molecule, confirms these indications (38). The 
contribution of the described post-translational modifications has also been investigated. The 
immunological reactivity of both epitopes is not influenced by the presence of the glycosyl 
groups but is likely to be dependent on the presence of the acyl groups (35). Whether the 
acyl groups are an integral part of the epitopes or only contribute to the formation and 
maintenance of the epitopes is not clear. 
Several other proteins (e.g. 40/10-kDaand 30-kDa) of the sexual stages of P.falciparum may 
also play an important role in transmission blocking immunity (24). However, little data 
about these proteins is available. The attribution of a possible role for these proteins in 
transmission blocking immunity should depend on positive results in transmission blocking 
assays. 
Natural occurrence of transmission blocking antibodies 
Relatively few investigations have been carried out on the occurrence of transmission 
blocking antibodies in individuals exposed to P.falciparum and P.vivax (reviews 1,24,64). 
In a first report (1986), the presence of transmission blocking antibodies in serum samples 
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of P.falciparwn patients in New Guinea and of a patient returning from Africa were 
demonstrated in membrane feeding experiments (65). 
The gamete surface proteins of 230-kDa, 48-kDa and 45-kDa are potentially capable of 
inducing an immune response during natural infections of P.falciparum, since these proteins 
are already present in the gametocytes of P.falciparum. Indeed, the main gamete surface 
antigens recognized by sera of individuals exposed to P.falciparum malaria transmission in 
Papua New Guinea were the 230-kDa, 48-kDa and 45-kDa proteins (66,43). Also, an internal 
protein induced an immune response as was shown by the presence of anti 27-kDa 
antibodies, in most of all sera tested (44). Furthermore, in a recent study (67), cross 
reactions between P.falciparum and P.vivax gametocyte antigens have been observed. 
For the different gamete surface antigens, the antibody response varied considerably between 
the various serum samples, suggesting that individuals respond differently to each gamete 
surface antigen (43,44). An explanation for the different immune response could be an MHC-
restriction of the immune response to the gamete surface antigens in the human population 
(44). 
Much work was involved in the demonstration of a correlation between the transmission 
blocking capacity of a serum sample and the presence of antibodies against the major target 
antigens (Mr 45/48-kDa and 25-kDa) of P.falciparum gametes (Beckers & Roeffen, personal 
communication). However, no such correlation could be found, indicating that other factors -
e.g. other epitopes on the known target antigens, other target antigens on the surface of 
gametes or other unidentified serum components- must be involved in the transmission 
blocking capacity of a serum. In Papua New Guinea, a correlation was reported between the 
presence of anti-230-kDa antibodies and suppression of infectivity of P.falciparum 
gametocytes to mosquitoes in membrane feeding experiments (43). However, the importance 
of this correlation, particularly with regard to the complement dependent effect of these anti-
gamete antibodies on the natural transmission of malaria, is not yet clear. 
The anti-gamete, transmission blocking antibodies may be readily induced during 
human malaria infections with P.falciparum (67) or P.vivax (52). After a primary attack of 
P.vivax, 50% of the tested sera contained antibodies directed against gamete surface antigens 
and this percentage increased during subsequent attacks. These antibodies suppressed the 
infectivity of P.vivax gametocytes to mosquitoes, and in many sera a heat-labile factor, 
presumably complement, seemed to be involved in the suppressive activity (52). 
In membrane feeding experiments with P.vivax, a remarkable phenomenon has been 
observed: sera with low antibody titres enhanced transmission compared to normal serum 
(52). The same effect was shown in studies with polyclonal antibodies and with monoclonal 
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antibodies against the 42-kDa and 36-kDa proteins of P.vivax (68). However, in membrane 
feeding experiments with P.falciparum gametocytes, no enhancement of transmission was 
observed when the antibody titres were low (69). It was shown that there is no simple 
relationship between gametocyte numbers, concentration of antibody against gamete antigens, 
and infectivity. 
A TRANSMISSION BLOCKING VACCINE: DREAM OR REALITY ? 
Investigations of the basic aspects, such as amino acid sequences of the stage-specific 
proteins, DNA-sequences of genes encoding for these proteins and their posttranslational 
modifications, necessary for the development of a transmission blocking vaccine, are 
hampered by many technical problems. 
After the cultivation of gametocytes and gametes, and the establishment of in-vitro infection 
of mosquitoes (2) progress has been made in the development of a gamete vaccine. The 
target antigens of transmission blocking antibodies, which are the potential candidates to be 
a part of the gamete vaccine, have been readily identified and characterized. However, after 
this promising start, attempts to identify genes encoding these antigens by screening of 
cDNA-expression libraries in E.coli with immunological probes have not been successful. 
The major problem was the tertiary structure maintained by disulphide bonds of the В cell 
epitopes on the most important target antigens (48/45-kDa and 25-kDa) of P.falciparum 
(35,38). Therefore, another approach had to be followed in order to isolate the genes 
encoding these antigens. 
An alternative approach is to obtain amino acid sequence information of the target 
antigens and to synthesize a probe derived from this sequence to screen a cDNA library. 
Proteins can be sequenced from the N-terminus, unless the N-terminus is blocked. In that 
case, the protein has to be cleaved in order to create new N-termini suitable for sequence 
analysis. Most of the eukaryotic proteins (80-90%) are N-terminally blocked and this is also 
the case for the 25-kDa protein of P.falciparum (38,Ch.5). Much effort has been invested 
to purify the most important target proteins of P.falciparum (48/45-kDa and 25-kDa) and 
lead to internal sequences for these proteins. Oligonucleotide probes derived from these 
internal sequences were used to screen cDNA libraries (38,Ch.5,Ch.6). 
At this moment, the sequence of the 25-kDa protein of P.falciparum is known. Attempts to 
clone the gene encoding this protein, in order to express the whole protein or parts of the 
protein (peptides) in an eukaryotic expression system are in progress and until now partial 
16 
successful! (70). This protein must be cloned in an eukaryotic system, since prokaryotic 
systems cannot provide the posttranslational modifications necessary for the formation and 
establishment of the В cell epitopes recognized by the available transmission blocking 
antibodies. 
In addition to these difficulties, many other problems must also be overcome before 
an effective vaccine can be developed. The importance of both Τ cell epitopes and В cell 
epitopes has been described for many synthetic vaccines including the malaria vaccines based 
on merozoite and sporozoite antigens (71,72). Vaccines based on a combination of В and Τ 
cell epitopes will be much more effective than a vaccine based only on an antibody-mediated 
immunity, since natural antibody boosting following a parasite challenge requires host 
recognition of Τ sites on antigens of parasite origin. Only recent investigations of the 
influence of Τ cell immunity in mice revealed that the cell-mediated immunity is also an 
important aspect in transmission blocking immunity (42). Studies of Τ cell epitopes on 
gamete antigens have been recently begun and established already the presence of Τ cell 
epitopes (41). However, the localization and the character of these epitopes are still 
unknown. 
Reports of immune response studies in human populations suggested that the natural immune 
response is probably MHC-restricted (44). But variable immune responses were also found 
in individuals with the same MHC-pattem (73). So, the variability in the immune response 
in the human population can be due to a МНС-restriction or to an antigen-specific immune 
suppression. This leaves the role of the Τ cell-mediated immunity in the case of the 
transmission blocking immunity unclear. 
Another problem is host mimicry, a way for the parasite to escape immunity (71). 
Host mimicry, which can result in Τ cell tolerance to malaria sequences, has been described 
for sporozoite and merozoite antigens and also for the 25-kDa protein of the gametes on 
P.falcipanm. The amino acid sequence of the 25-kDa protein showed to contain segments 
homologous with the epidermal growth factor (38). This implies that during vaccine trials 
with these antigens, the development of auto-antibodies must be carefully monitored. 
Antigenic polymorphism is also a hindrance in the development of a vaccine, since 
vaccine-induced protection will have to be effective against a wide spectrum of parasite 
populations. Antigenic variation is a well described phenomenon particular to asexual 
parasites in P.falciparwn and P.vivax (74-78). Until now only limited variation has been 
observed in gamete antigens of different P.falciparwn isolates (54,79). In addition, 
comparison of the primary structure of the 25-kDa protein of P.falciparwn and 
P.gallinaceum ookinetes showed highly conserved regions (80). This protein is therefore a 
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suitable candidate for a vaccine. 
Although the target proteins of transmission blocking antibodies are potential 
candidates for a gamete vaccine, the question remains how to booster the immunity to these 
proteins. The 230-kDa and 48/45-kDa proteins are already present in the gametocytes and 
it has been shown that the host immune response recognize these proteins. However, a great 
variability in response was observed in a human population (43,44,66). On the contrary, the 
25-kDa protein is present in very limited quantities in the gametocytes and until now 
antibodies against this protein have not been found in men exposed to natural infections, 
Therefore, a boosting effect can be expected for the 230-kDa and 48/45-kDa proteins but 
hardly for the 25-kDa protein. The advantage of this aspect is, that the selection of the 
parasite, in order to escape from the host immune response, is not likely to happen since the 
25-kDa protein is not subjected to any form of immune pressure. 
In human infections with P.vivax, a rather inefficient natural longevity of the humoral 
response has been observed in transmission blocking immunity (81). Thus, the individual 
differences and the duration of an immune response of humans to the gamete surface antigens 
are of great importance for the ultimate effect of a transmission blocking vaccine. At this 
moment, little is known about the effect of immunity on the natural transmission of the 
parasite to the mosquito vector. 
The enhancement of the production of sporozoites, by transmission blocking antibodies or 
by anti-sporozoite antibodies, was also reported as a possibility to evade the host immune 
response and ensure survival of the parasite (82). However, a recent study revealed that the 
amount of sporozoites is less important than the mosquito density for the vectorial capacity 
in the transmission of the parasite from mosquitoes to man (83). As can be expected, the 
intensity of transmission will also be a substantial factor in the effect of a transmission 
blocking vaccine. In areas with a low level of transmission, a gamete vaccine, possibly in 
combination with other control measures, might eliminate malaria, while in areas with a high 
level of transmission a gamete vaccine would probably have little effect. 
Although immunity to the sexual antigens would prevent direct transmission of the 
vertebrate host to the mosquitoes, immunity to other stages in the life cycle (sporozoites, 
merozoites) inhibits the transfer of parasites as well, although in an indirect manner. Studies 
of sporozoite and merozoite vaccines are more advanced than the gamete vaccines and the 
first vaccine trials have been performed. However, a complete protection against a 
subsequent challenge have not been obtained in these trials (84-87). The major problems are 
the recognition of the proper Τ cell sites and antigenic diversity. This antigenic diversity may 
be due to the rapid multiplication in the blood and to the immune pressure of the host. 
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Immunization tends to select parasites expressing antigens not present in the vaccine. The 
way to prevent the spread of such a resistant form would be to prevent their transmission to 
the mosquito vector. The combination of the three components, sporozoite, merozoite and 
gamete antigens, in a malaria vaccine would provide protection for the host and additionally 
provide reduction of the risk of malaria and the spread of parasite mutants. It is therefore 
important to concentrate on all three stages, on different areas (immunology, biology and 
biochemistry), for the development of a malaria vaccine. 
In conclusion, the development of a malaria vaccine and particularly the transmission 
blocking component, still requires much effort from biochemists, molecular biologists, 
immunologists and epidemiologists before this dream can be realized. 
OUTLINE OF THIS THESIS 
In order to expand the knowledge on the targets of transmission blocking antibodies, 
we have studied the 48/45-kDa protein and the 25-kDa protein of P.falciparum gametes and 
ookinetes in detail. In Chapter 2, the biosynthesis of the 25-kDa protein in gametes and 
zygotes is described. The detailed characterization of the В cell epitopes, especially the 
contributions of the posttranslational modifications to these epitopes, on the 25-kDa protein 
(Chapter 3) and on the 48/45-kDa proteins (Chapter 4) are also presented. The nature of the 
В cell epitopes forced us to isolate and purify the target antigens, in order to obtain an amino 
acid sequence which was suitable for the cloning of the genes encoding these target antigens. 
The isolation and purification of the 25-kDa protein and the 48/45-kDa proteins, which were 
hampered by many technical problems, are described in Chapter 5 (25-kDa protein) and 
Chapter 6 (48/45-kDa proteins). 
Immunological and biochemical knowledge of the target antigens of P.falciparum for 
transmission blocking antibodies is a contribution to the development of a malaria vaccine. 
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SUMMARY 
Synthesis of the 25-kDa protein in the early midgut stages of Plasmodium falciparum 
was studied using metabolic inhibitors (colchicine and actinomycin D) and pulse-labeling 
experiments. 
Experiments with colchicine showed that, immediately after induction of 
macrogametogenesis, 25-kDa protein synthesis occurs in both fertilized and nonfertilized 
macrogametes. The amount of 25-kDa protein synthesized increased slowly during time. 
Experiments with actinomycin D revealed that the slow increase of synthesis may be 
dependent on de novo messenger RNA synthesis. 
INTRODUCTION 
The sexual and sporogonie growth cycle of malaria parasites consists of 
morphologically and physiologically distinct phases: microgametocytes and 
macrogametocytes, microgametes and macrogametes, zygotes, ookinetes and oocysts. The 
development of mature gametocytes into gametes is induced by the exposure of gametocytes 
to a drop in temperature and a decrease of pCO, (1,11). This occurs under natural 
circumstances when mature gametocytes are ingested by female mosquitoes during a 
bloodmeal. While progressing through these stages, the parasite (especially the microgamete) 
enters a period of DNA synthesis and expresses stage-specific proteins (5,7,14). 
In Plasmodium falciparum, stage-specific membrane proteins of the extracellular 
macrogametes/zygotes are important targets for transmission blocking antibodies. Earlier 
studies have demonstrated that two major target antigens, present on the surface of freshly 
emerged macrogametes (non-reduced Mr 230,000 and 48,000/45,000), are synthesized in the 
gametocytes (7,15). A third major target antigen (non-reduced Mr 25,000) is present on the 
surface of macrogametes/zygotes and developing ookinetes. Although synthesized at a low 
level during gametocytogenesis, the 25-kDa protein is predominantly synthesized after 
gametogenesis (15). 
During the present study, the biosynthesis of the 25-kDa protein was investigated in more 
detail using the metabolic inhibitors colchicine and actinomycin D. These inhibitors inhibit, 
respectively, the fertilization and the production of mRNA during the development of the 
gametes. Therefore, experiments with these inhibitors can give some information about the 
29 
regulation of the 25-kDa protein synthesis. The dynamics of the 25-kDa protein synthesis was 
investigated by pulse-labelling experiments. 
MATERIALS AND METHODS 
Parasites 
Mature gametocytes of P.falciparwn (isolate NF 54) were produced in a semi-
automated culture system (static) as described by Ponnudurai et al. (9). Gametocytes were 
obtained from asynchronous parasite material and purified on 18% (v/v) Nycodenz cushions 
by centrifugation for 15 min at 3000 rpm at 370C (to prevent activation of the mature 
gametocytes) as described by Vermeulen et al. (15). Gametocyte activation was initiated by 
incubating the parasites at room temperature (t = 0 min in all experiments). 
Metabolic labelling 
General procedure: Radiolabelling of proteins synthesized during gametogenesis and 
ookinete formation was performed by incubating 50 x 10* gametocytes in 1 ml methionine-
free RPMI 1640 containing 24 mM NaHCOj, 10% FCS (pH 7.8) and 250 /xCi/ml "S-
methionine (Amersham spec. act. 1200 μίϋί/πιπιοί). At different time points, parasites 
samples were taken, frozen in solid CCyethanol and stored at -20oC until use. 
Four types of metabolic labelling experiments were performed: 
(1) Labelling in the presence or absence (control) of 0.75 mg/ml Colchicine (Sigma) for two 
or five hours. 
(2) Cumulative synthesis of the 25-kDa protein was analysed by labelling parasites from t = 
-5 min (before activation) until t = 300 min after activation. 
(3) The rate of 25-kDa protein synthesis was followed during 11 sequential non-overlapping 
30-min pulses. Before pulsing, isolated gametocytes were washed, activated and held 
metabolically active in complete RPMI 1640 supplemented with 10% FCS (pH 7.8). 
(4) To measure the effect of actinomycin D on protein synthesis, parasites were pulse 
labelled during 5 sequential non-overlapping intervals of 10 min in the presence or absence 
(control) of 5 jig/ml actinomycin D (Sigma) as described by Silva et al. (10). 
SDS-PAGE, fluorography and densitometric scanning 
Parasite membrane proteins were solubilized as described by Fries et al. (2), and 
0.5 x 10' parasites per lane were electrophoresed on 4-20% gradient acrylamide gels (under 
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non-reducing conditions) according to the procedure of Laemmli (8). 
Following electrophoresis, the gels were saturated with 1 M sodium-salicylate/10% glycerol 
for 1 h, dried under vacuum and exposed to Kodak XAR 5 films at -80eC. The 25-kDa 
protein signal was determined densitometrically (Laser Densitometer, Biorad) and taken as 
a measure for the amount of 25-kDa protein synthesized. 
Total incorporation of label in membrane proteins was determined by liquid scintillation 
counting. From each solubilized protein sample, 1 /tl was diluted with 4 ml Aqua Luma Plus 
(Scintillation fluid) and counted for 1 min in a Perkin-Elmer liquid scintillation counter. The 
percentage label incorporated in the 25-kDa protein, was estimated by counting immuno-
precipitated 25-kDa protein. 
Two-site ELISA 
The immunological activity of newly synthesized 25-kDa protein was assessed using 
a two-site ELISA as described by Fries et al. (2). The mabs (FPLC-purified IgG) used in the 
two-site ELISA were the transmission-nonblocking 32F72 and the transmission-blocking 
32F81. The production and purification of the mabs are described by Vermeulen et al. (14). 
RESULTS 
Colchicine was used to obtain information on 25-kDa protein synthesis at initiation 
of activation, without subsequent zygote formation. Colchicine blocks microtubule formation 
during the process of microgamete formation (exflagellation), but does not prevent the release 
of the parasite from its erythrocytic host cell, and thus indirectly inhibits zygote formation. 
In the absence of colchicine (control), exflagellation proceeded normally. After labelling 
macrogametes with 35S-methionine in the presence of colchicine, and a mixture of 
macrogametes/zygotes (control culture) for 2 and 5 hr, there was no difference in protein 
synthesis (Fig. 1, lanes 1-4). 
The dynamics of protein synthesis were investigated immediately after the induction 
of the gametogenesis. Parasites were metabolically labelled from 5 min before activation until 
5 hr after activation. At different time points (as indicated in Fig. 2A), samples were taken 
to assess the cumulative synthesis of the 25-kDa protein. Figure 2A shows the fluorograph 
of the different samples. Expression of this protein was already detectable within 2.5 min 
after activation (Fig. 2A) and continued throughout the experiment. The progressive increase 
in the 25-kDa protein signal reflects an accumulation of this protein. The amount of 
31 
Figure 1. Autoradiogram after SDS-PAGE (non-reducing conditions) of 35S-methionine labelled proteins 
of macrogametes (presence of colchicine) and a mixture of macrogametes/zygotes (absence of colchicine). 
Lane 1 : Total macrogamete proteins after 2 hr labelling. Lane 2: Total macrogamete/zygote proteins after 
2 hr labelling. Lane 3: as lane 1 but after S hr labelling. Lane 4: as lane 2 but after 5 hr labelling. 
Standard proteins; myosine (Mr 200,000), ß-galactosidase (Mr 116,000), Phosphorylase В (Mr 97,000), 
bovine serum albumin (Mr 66,000), ovalbumin (Mr 43,000), carbonic anhydrase (Mr 31,000), soybean 
trypsin inhibitor (Mr 21,500). 
immunologically reactive 25 kDa protein also similarly increase during this period, as 
determined in a two-site ELISA (Fig. 2B). This indicates that the newly synthesized 25-kDa 
protein is immunologically reactive directly after synthesis. 
The course of 25-kDa protein synthesis was estimated during pulse-labelling 
experiments (with pulses of 30 min). Figure ЗА shows the fluorograph of one of several 
experiments, and Figure 3B shows the percentage label incorporated in the 25-kDa protein 
during each pulse (two different experiments). For all pulse periods, between 0.6 and 3.3% 
of label was incorporated in the 25-kDa protein. This indicates that the amount of synthesized 
protein is comparable for all pulse periods. Differences in the absolute amounts of 
incorporated label between individual parasite cultures (as can been seen in Figures 1, 2A, 
ЗА and 4A), probably reflect differences in the metabolic activity of individual parasite 
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Figure 2A. Fluorograph after SDS-PAGE of 33S-labelled proteins. Samples were taken from time t = -5 min, 
before activation, until t = 300 min, after activation, as indicated above each lane. 
The 25-IcDa protein is indicated by an arrow. 
cultures. In both experiments, synthesis increases after 30 min (in the second period). This 
is also observed for other proteins which are newly synthesized at the same time in the 
macrogametes/zygotes. 
Experiments with actinomycin D were performed to determine the effect of the 
OD •(SOnm 
Figure 2B. Results of two different 
experiments (•, + ) in the two-site 
ELISA. The measured OD 450 nm is 
plotted against each time point at which 
samples were taken for the analysis of 
the immunological activity of the newly 
synthesized 25-kDa protein. 
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Figure 3. A: Fluorograph after SDS-PAGE of '5S-Iabelled proteins during 11 sequential non-overlapping 
intervals of 30 min. The end of each time period is indicated above the lanes. Standard proteins were as in 
Figure 1. 
B: Percentage label incorporated in the 25-kDa protein plotted against each time period. 
inhibition of DNA transcription on protein synthesis. At low concentrations, actinomycin D 
inhibits DNA transcription without directly inhibiting protein synthesis (3). The amount of 
label incorporated during 10-min labelling periods in the presence and absence (control) of 
actinomycin D is nearly the same, indicating that protein synthesis proceeds normally (data 
not shown). Figure 4A shows the fluorograph and Figure 4B shows the corresponding 
densitometric scanning measurements of the 25-kDa protein signal. The fluorograph shows 
a negative effect on protein synthesis when actinomycin D was added to the culture medium. 
This negative effect is seen most clearly for the 25-kDa protein and some other low 
molecular weight proteins and less for the proteins with higher molecular weights. The 
densitometric scanning confirms the results seen on the fluorograph. In the first time period, 
however, more 25-kDa protein is synthesized in the culture with actinomycin D. This protein 
production comes from mRNA, already produced in the gametocyte. Actinomycin D has no 
effect on the 25-kDa production, when the drug is added to the culture medium, 2 hr after 
induction of gametogenesis (Fig. 4B, time period 6). 
DISCUSSION 
Activation of gametocytes or fertilization of macrogametes may induce an increased 
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Figure 4. A: Fluorograph after SDS-PAGE of 55S-labelled proteins during five sequential non-overlapping 
intervals of 10 min in the absence (panel A) and presence (panel B) of 5 /xg/ml Actinomycine D. The end of 
each time period is indicated above the lanes. (M
r
= standard proteins as indicated in Figure 1). 
B: Density of the 25-kDa protein signal from the fluorograph plotted against each time period. (For the control 
in period 1 and the actinomycin D culture in period 3, no density of the 25-kDa protein could be measured.) 
Time period 6: Density of the 25-kDa protein signal from the fluorograph (data not shown), after labelling for 
30 mm, 2 hr after induction of activation of gametocytes. 
synthesis of the 25 kDa-protein. This was investigated using the metabolic inhibitors 
colchicine and actinomycin D, and with pulse-labelling experiments. 
Fertilization of the macrogametes can be prevented by the inhibition of exflagellation 
of the microgametocytes by colchicine, as was shown for P.yoelii nigeriensis (13). However, 
the complete inhibition of the exflagellation has no effect on the 25-kDa protein synthesis. 
This indicates that fertilization has no influence on the 25-kDa protein synthesis rate in the 
macrogamete. The macrogamete synthesizes the 25-kDa protein immediately after activation 
in the same way as the zygotes. 
Cumulative labelling experiments showed that 5 min before induction of 
gametogenesis, the 25-kDa protein is not synthesized in the mature gametocytes. After 
activation the amount of 25-kDa protein synthesized increased slowly during time. 
Pulse-labelling experiments (from activation (t = 0)) also confirmed that the rate of 
25-kDa protein synthesis is low immediately after the induction of gametogenesis. Thirty 
minutes after activation, a rate of synthesis is reached that remains nearly constant for at least 
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5 hr. The rate of synthesis differs for each parasite batch, but the reason for this phenomenon 
is unknown. A particular time point at which the rate of synthesis suddenly increases was not 
detected in these experiments. From these results it can be concluded that the protein 
probably has a very low turnover. Pulse-chase-labelling experiments showed almost no 
differences in the amount of labelled 25-kDa protein during the pulse and chase periods (data 
not shown). 
A possible explanation for the slow increase of the 25-kDa protein synthesis 
immediately after activation could be the dependence on the synthesis of new messenger 
RNA for the 25-kDa protein. However, messenger RNA from gametocytes has an abundance 
of a mRNA species that hybridizes with the genomic DNA fragment which codes for the 25-
kDa protein (6; Schoenmakers, personal communication). Actinomycin D, an inhibitor of 
mRNA production (3,10,12,13), inhibited 25-kDa protein synthesis when the drug was added 
to the culture medium at the time of activation. Only a small amount of protein (8% of the 
control culture) is synthesized in the presence of actinomycin D. This result indicates that 
while some messenger RNA for the 25-kDa protein is present in gametocytes, mRNA 
encoding the 25-kDa protein is mainly synthesized after activation of the gametocytes. The 
induction of de novo mRNA not due to a fast mRNA-turnover since actinomycin D has no 
effect on protein synthesis 2 hr after activation and ex flagellation. However, the occurence 
of specific ribosomes, of which the transcription is restricted to a specific stage of the life 
cycle of the parasite (4), could account for the described findings. Sinden and Smalley (12) 
showed the same effect of actinomycin D; namely, an inhibition of protein synthesis in the 
first development period of gametocytes and no effect on mature gametocytes. 
The action of the metabolic inhibitors used in this study has given new insights in the 
regulation of synthesis of the 25-kDa protein. A time of induction of 25-kDa protein 
synthesis was not detected. The inhibitory effect of actinomycin D, mainly on the 25-kDa 
protein synthesis, however, suggests that other factors are involved in the regulation of the 
25-kDa protein synthesis. 
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SUMMARY 
A sexual stage specific protein of Plasmodium falciparum with a Mr of 25,000 is one 
of the target antigens of transmission- blocking antibodies. The contributions of tertiary 
structure and posttranslational modifications (glycosylation and acylation) to the structure of 
the epitopes on this protein were the subject of detailed investigations. After modification of 
the three- dimensional structure and modification or cleavage of carbohydrate groups and 
linked fatty acids, the immunological reactivity was investigated by three different 
techniques: (i) immunoprecipitation of radiolabelled proteins, (ii) enzyme-linked-
immunosorbent assay (ELISA) and (iii) Western-blotting. 
The results of the experiments indicate that the immunological reactivity of the major 
epitopes on the 25-kDa protein, including the epitope involved in transmission-blocking 
immunity, are dependent on the tertiary structure of the protein and on the presence of linked 
fatty acids, but not on the presence or absence of carbohydrate groups. 
INTRODUCTION 
Previous studies have demonstrated that the development of the malaria parasite in 
the mosquito midgut can be inhibited by anti-gamete antibodies ingested during the bloodmeal 
(3,7). One of the major Plasmodium falciparum proteins (Mr 25,000), present on the surface 
of developing zygotes/ookinetes, is a target antigen for transmission blocking antibodies (20). 
This protein is posttranslationally modified by glycosylation and acylation (21). With respect 
to the development of a transmission blocking vaccine utilizing recombinant DNA or 
synthetic peptide technology, it is important to establish whether these posttranslational 
modifications of the 25 kilodalton (kDa) protein form an integral part of the epitopes 
recognized by the transmission blocking antibodies. Furthermore, this information is relevant 
with regard to the immunological screening ofE.coli expression libraries in order to identify 
the antigen encoding DNA sequences. It has been demonstrated that the carbohydrate moiety 
of some glycoproteins of the asexual stages of the parasite contribute to the immunological 
reactivity of these proteins (13). In order to assess the contribution of the carbohydrate 
groups to the epitopes on the 25-kDa protein, its immunological reactivity was tested after 
(i) modification and (ii) removal of the carbohydrate groups. Furthermore, we tested the 
immunological reactivity of the deacylated 25-kDa protein in order to ascertain whether acyl 
groups contribute to the structure of the epitopes. The major epitopes of the 25-kDa protein 
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are probably conformation-dependent since monoclonal and polyclonal antibodies do not react 
with the reduced protein on Western blots (20). If conformational epitopes are recognized, 
it is essential to determine their structure in order to assign experimental conditions that 
promote the folding of the protein into its immunologically reactive conformation. In this 
paper we present the results of our studies on these epitopes present on the P.falciparum 25-
kDa target antigen of transmission blocking antibodies and discuss the results with regard to 
the development of a transmission blocking vaccine. 
MATERIALS AND METHODS 
Parasites 
Mature gametocytes of P.falciparum (isolate NF 54) were produced in a 
semi-automated culture system as described by Ponnudurai et al. (12). Gametogenesis was 
induced by incubating the mature gametocytes in fetal calf serum (FCS) at room temperature 
for 30 min. Macrogametes/zygotes were purified as described by Vermeulen et al. (20). 
Radiolabelling 
Biosynthetic labelling was performed by incubating 3 X 107 purified 
macrogametes/zygotes in 1 ml methionine-free RPMI 1640 medium containing 24 mM 
NaHCOj, 10% FCS (pH 7.8) and 250 μΟί "S-methionine (Amersham spec. act. 1200 
/iCi/mmol) for up to 4 h at room temperature. For biosynthetic labelling with 'H-palmitic 
acid or 3H-myristic acid, the purified macrogametes/zygotes were incubated in 1 ml medium 
199, 10% FCS 3 (pH 7,8) and 100 /tCi 3H-palmitic acid (Amersham spec. act. 55 μα/πιπιοί) 
or 100 /tCi 3H-myristic acid (Amersham spec. act. 55 /iCi/mmol). 
Solubilization 
Purified macrogametes/zygotes were solubilized in 25 mM Tris-HCl (pH 8.0) 
containing 0.5% Nonidet P-40 and 1 mM phenylmethylsulfonylfluoride for 30 min at room 
temperature. After centrifugation for 10 min at 18,000 g, the sediment was discarded and the 
soluble protein extract stored at -20° С or -80° С until use. 
Monoclonal and polyclonal antibodies 
Monoclonal antibodies (mabs) produced against the surface proteins of P.falciparum 
macrogametes/zygotes (20). were used in this study. Some of the monoclonal antibodies 
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blocked the development of the parasite in the vector when these were included in the 
infective feed, whilst others did not (20). They are called 'blockers' and 'non-blockers' 
respectively. The following monoclonal antibodies were used (as hybridoma supernatant or 
FPLC-purified IgG): 32F81 (anti 25-kDa, blocker), 32F71 (anti 25-kDa, non-blocker). A 
polyvalent, transmission blocking, rabbit anti macrogamete/zygote serum (K 1771) and a 
polyclonal rabbit anti mouse (RAM) IgG fraction were prepared as described (20). 
Immunoprecipitation and identification of radiolabelled proteins 
The immune reactions were carried out using a solid phase immuno-assay. 
Polyvinylchloride microliter plates were coated with the appropriate FPLC-purified 
monoclonal IgG at a concentration of 20 μg/ml in phosphate buffered saline (PBS) for 18 h 
at room temperature. The wells were saturated with 2% BS A in PBS by incubation for 1 h 
at room temperature. Fifty μΐ of a radiolabelled, solubilized protein extract (equivalent to 
1 x 106 macrogametes/zygotes) was added to each well and incubated for 18 h at 4"C. The 
plates were extensively washed with 0.05% Tween-20/PBS (TPBS). Bound protein was 
eluted from the wells with 30 μΐ SDS-sample buffer (62 mM Tris-HCl (pH 6.8), 2.5% SDS, 
0.005% Bromo-phenol blue, 5% glycerol). The samples were electrophoresed through 4-20% 
Polyacrylamide gels containing 10% SDS, as described by Laemmli (11). Following 
electrophoresis, the gels were saturated with 1 M sodium-salicylate/10% glycerol for 1 h, 
dried and fluorographed on Kodak XAR 5 film at -80eC. 
Enzyme-linked-immunosorbent assay (ELISA) 
Immune reactions were carried out at room temperature in a two-site 
enzyme-linked-immunosorbent assay (ELISA) as described by Verhave et al. (19). Microliter 
plates were coated with mab as described above. The wells were saturated with 0.25% 
milkpowder/0.05% Tween-20/PBS (MTPBS) by incubation for 1 h. After three washings 
with TPBS, 50 μΐ of a solubilized protein extract or a modified protein extract (as described 
below), equivalent to 5 x 105 macrogametes/zygotes, was added to each well and incubated 
for 2 h. Following three washings with TPBS, the plates were incubated with 50 μΐ biotin 
labelled mab (6 μg/ml MTPBS) for 3 h. After another three washings with TPBS, the wells 
were incubated for 30 min with streptavidin-biotinylated peroxidase complex (Amersham; 
1:1500 diluted in MTPBS). The wells were then washed three times with TPBS and 
incubated with 60 μΐ substrate solution (100 mM citric acid, 200 mM NajHPC^ (pH 5.0), 
containing 0.34 mg/ml o-phenylene diamine and 0.006% H202) for 30 min in the dark. The 
enzyme reaction was stopped by adding an equal volume of 4 N H2SO4. The absorbance at 
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492 nm was measured in an ELISA-reader. When tetramethylbenzidine was used as a 
substrate, the absorbance was read at 450 nm. 
Western blotting and immunodetection 
Protein samples were solubilized or diluted with SDS-sample buffer and 
electrophoresed through 4-20% SDS-polyacrylamide gel under non-reducing conditions. 
Immediately after electrophoretic separation, the slab gel was incubated in 10 mM Tris-HCl 
(pH 8.3), 80 mM glycine, 10% methanol for 30 min. Proteins were electrophoretically 
transferred onto nitrocellulose paper as described (20). For immunodetection, blots were 
incubated in hybridoma supernatants, diluted one hundred fold in PBS/0.1% BS A/0.05% 
Tween-20. Antibody reactions were detected by incubating the blots in 12iI-protein A solution 
(Amersham, specific radioactive concentration 100 ¿iCi/ml) and visualized by 
autoradiography at -80oC using Kodak XAR 5 film with screen amplification. Alkaline 
phosphatase conjugated to rabbit-anti-mouse IgG (RAM-АР; Sigma) was also used to 
visualize the primary antibody reaction (2). For this purpose the nitrocellulose blot was 
incubated with RAM-АР (dilution 1:2000 in TPBS) for 30 min at room temperature. After 
three washes with TPBS, the bound alkaline phosphatase activity was detected with a mixture 
of 0.05 mg/ml 5-bromo-4-chloro- 3-indolyl phosphate p-toluidine salt (Sigma) and 0.1 mg/ml 
nitro blue tetrazolium (Sigma) in 0.1 M Tris-HCl (pH 9.5), 0.1 M NaCl, 5 mM MgCl for 
1-4 h at room temperature. After incubation, the blot was washed with water and dried 
between Whatman 3 MM paper. 
Reduction and Carboxymethylation 
The protein extract from 5 to 10 x 106 macrogametes/zygotes was diluted to a 
volume of 200 μΐ with a freshly prepared buffer containing (as final concentrations): 0.2 M 
Tris-HCl (pH 8.2), 1 mM EDTA and either 8 M urea (ultra pure, BRL) or 6 M 
guanidine-HCl (Sigma) (flushed with N2 prior to use). After denaturation of the protein 
extract for 30 min, reduction was carried out for 60 min at room temperature by the addition 
of 20 μΐ 1.5% dithiothreitol (DTT). In order to prevent reassociation of the SH-groups 
formed during the reaction, carboxymethylation was performed by adding 20 μΐ 4% 
iodoacetamide (BDH, England) or 20 μΐ 4% iodoacetic acid (Sigma) and incubating the 
mixture in the dark for 60 min at room temperature (17). Excess reagents were removed by 
overnight dialysis against 25 mM Tris-HCl (pH 8.0), 150 mM NaCl, 0.1% Nonidet P-40. 
44 
Periodate oxidation 
The periodate oxidation was carried out in combination with a two-site ELISA 
(19,23). Polyvinylchloride microliter plates were coated with the appropriate FPLC-purified 
mab IgG as described above. The wells were saturated with MTPBS by incubation for 1 h 
at room temperature. After three washings with TPBS, 50 μΐ protein extract, equivalent to 
5 Χ 105 macrogametes/zygotes, was added to each well and incubated for 2 h. Following 
five washings with TPBS, the plates were washed two times with 50 mM sodium acetate (pH 
4.5). Bound proteins were then exposed to 10 mM periodate in 50 mM sodium acetate for 
1 h in the dark (23). After two washings with 50 mM sodium acetate, the aldehyde groups 
formed during the reaction were blocked by incubation with 1 % glycine in PBS for 30 min. 
Both the periodate and glycine solutions were prepared immediately prior to use. After five 
washings with TPBS, the wells were incubated with the appropriate biotin-labelled mab for 
3 h and the ELISA was completed as described (19). The substrate used was 
tetramethylbenzidine (TMB). All reactions were carried out at room temperature. 
Deglycosylation (Trifluoromethanesulfonic acid treatment) 
Deglycosylation was carried out essentially as described by Shy et al. (16). Briefly, 
15 X IO6 macrogametes/zygotes were resuspended in 50 /Л 10 mM PMSF, incubated for 30 
min at 4CC and lyophilized. The lyophilized parasites were solubilized in a mixture of 45 /il 
trifluoromethanesulfonic acid (TFMS, Sigma) and 5 μΐ anisóle (Aldrich). The solution was 
saturated with nitrogen for 45-60 s and incubated for 3 h on ice. During the incubation, the 
solution was vortexed every 30 min The deglycosylation reaction was stopped by the addition 
of 1 ml diethyl ether/pyridine (9/1, cooled to -40oC). The precipitate was pelleted by 
centrifugation at 2500 rpm for 10 min (minifuge gl, Heraus Christ) and lyophilized. The 
dried pellet was then dissolved in TNP-buffer (25 mM Tris-HCl (pH 8.0), 150 mM NaCl, 
0.1% NP-40) and dialyzed against TMP. Samples were tested on Western blots as described. 
Deacylation (Hydrolysis with potassium hydroxide) 
Hydrolysis of the acyl moiety was carried out on solubilized proteins of 
biosynthetically labelled macrogametes/zygotes (35S-methionine, 3H-palmitic acid, 3H-myristic 
acid) or on solubilized proteins of non-labelled macrogametes/zygotes. To 50 μΐ extract, 
equivalent to 10 x 10* macrogametes/zygotes, an equal volume of 0,1 M КОН in 20% 
methanol was added, and incubated for 90 min at room temperature. After neutralization with 
1 M HCl, the mixture was dialyzed against TNP and concentrated by ethanol precipitation. 
The precipitate was recovered by centrifugation and dissolved in SDS-sample buffer. Samples 
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were electrophoresed through 4-20% SDS-polyacrylamide gels as described by Laemmli (11). 
Following electrophoresis, the proteins were blotted as described. 
8 9 
21 -
Figure l.Fluorograph after SDS-PAGE of 35S-methionine labelled macrogamete/zygote proteins 
immunoprecipitated by mabs, after treatment with 6 M guanidine-HCI, DTT and iodoacetamide and subsequent 
dialysis as described in materials and methods. 
Lane 1: total 3SS-labelled proteins, lane 2: same as lane 1, but immunoprecipitated with mab 32F71; lane 3: 
same as lane 1, but immunoprecipitated with mab 32F81; lane 4 total 'SS-labelled proteins after denaturation, 
reduction and carboxymethylalion; lane S: same as lane 4, but immunoprecipitated with mab 32F71; lane 6: 
same as lane 4, but immunoprecipitated with mab 32F81; lane 7: total 35S-labelled proteins after denaturation 
and carboxymethylalion; lane 8: same as lane 7, but immunoprecipitated with mab 32F71; lane 9: same as lane 
7, but immunoprecipitated with mab 32F81. (Exposure time: 24 hours). Standard proteins: myosine (Mr 
200,000),ß-galactosidase (Mr 116,000), Phosphorylase В (Mr 97,000), bovine serum albumin (Mr 66,000), 
ovalbumin (Mr 43,000), carbonic anhydrase (Mr 31,000), soybean trypsin inhibitor (Mr 21,500). 
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Table 1. ELISA assay measuring the 25 kDa epitope recognition by blocking (32F81) and 
non-blocking (32F71) mabs after vanous treatments of macrogamete/zygote protein extracts (see 
materials and methods). 
Treatment 
denatured/reduced/alkylated 
denatured/reduced 
denatured/alkylated 
denatured 
non-treated 
32F71 
_ 
-
+ 
+ 
+ 
32F81 
_ 
-
+ 
+ 
+ 
- : no significant reaction with the mab 
+ : positive reaction with the mab 
RESULTS 
Reduction and carboxymethylation 
A solubilized 35S-radiolabelled protein extract of macrogametes/zygotes was denatured 
in 6 M guanidine-HCl and reduced with 10 mM DTT. Reassociation of the resulting free 
SH-groups was prevented by carboxymethylation with 20 mM iodoacetamide. As a control, 
a solubilized 35S-labelled protein extract was denatured and the original free thiol-groups were 
carboxymethylated. After dialysis the samples were analyzed by electrophoresis. Figure 1 
shows a fluorograph of the SDS-PAGE pattern of the non-treated sample (lane 1), the 
'carboxymethylated' sample (lane 4) and the 'control' sample (lane 7). As expected, the 25-
kDa protein in the non-treated sample could be immunoprecipitated by the mabs 32F71 
(non-blocker) and 32F81 (blocker) (lanes 2 and 3, respectively). The 'carboxymethylated' 
25-kDa protein shows a slight difference in electrophoretic mobility and appears as a band 
with a Mr of 27,000 (lane 4). Incubation with the mabs 32F71 and 32F81 revealed that the 
modified protein could not be immuno-precipitated (lanes 5 and 6, respectively). In the 
'control' sample (lane 7) the 25-kDa protein appears as a more diffuse band compared to the 
non-treated protein, but could still be immunoprecipitated by the mabs 32F71 and 32F81 
(lanes 8 and 9, respectively). Similar results were obtained in experiments using non-labelled 
protein extracts denaturated in 8 M urea instead of 6 M guanidine-HCl. In these experiments, 
one control sample was denatured in 8 M urea, and another was simultaneously denatured 
and reduced in 8 M urea containing 1.5% DIT. The resulting free SH-groups were not 
blocked by carboxymethylation. After these treatments, renaturation of the proteins was 
promoted by dialysis (see materials and methods) and the samples were analyzed by Western 
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1 2 3 4 5 
Figure 2.Western blotting of macrogamete-
/zygote proteins after treatment with 8 M urea, 
DTT and iodoacetamide, and sub-sequent dialysis 
as described in materials and methods. Lane 1: 
non-treated sample; lane 2: denatured, reduced 
and carboxymethylated sample; lane 3: denatured 
and reduced sample; lane 4: denatured and 
caiboxymethylated sample; lane S: denatured 
sample. The blot was screened using the 
hybridoma supernatant 32F71 (anti 25 kDa). The 
25 kDa protein is indicated by an arrow. 
blotting (Fig. 2) and in an ELISA (Table 1). The results of both analyses were comparable. 
After denaturation and carboxymethylation without reduction, the 25-kDa protein could still 
be detected with the anti 25-kDa mabs (Fig. 2, lanes 4 and 5; Table 1). The protein did not 
react with the mabs after denaturation, reduction and carboxymethylation (Fig. 2, lane 2; 
Table 1). Surprisingly, the mabs also failed to react with the 25-kDa protein (Fig. 2, lane 
3; Table 1) after denaturation and reduction without a subsequent blocking of the free 
SH-groups. Identical results were obtained when a polyvalent anti-gamete rabbit serum (K 
1771) was used instead of the mabs (data not shown). 
Modification and cleavage of the carbohydrate moiety 
Mild periodate oxidation at acid pH modifies the carbohydrate moiety of a protein by 
cleaving the vicinal hydroxyl groups without affecting the polypeptide backbone (23). Figure 
ЗА shows the effect of the periodate oxidation on the reactivity of the 25-kDa protein with 
the transmission blocking (B: 32F81) and non-blocking (NB: 32F71) mabs. The observed 
differences in reactivity between the blocking and non-blocking mabs may be due to 
differences in affinity for the protein. Only a slight decrease in immunological reactivity is 
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Figure 3. A. Effect of periodate oxidation of the 25 kDa protein on the binding of transmission blocking and 
non-blocking monoclonal antibodies. Closed bars represent the control samples (0 mM periodate) and open bars 
the treated samples (10 mM periodate). В: 32F81, blocking mab; NB: 32F71, non-blocking mab. Error bars 
indicate the standard deviation for quadruplicate samples. 
B. The effect of deglycosylation with TFMS on the immunoreactivity of the 25 kDa protein. Control samples 
(lanes a) and TFMS-treated samples (lanes b) were electrophoretically separated and transferred onto 
nitrocellulose. Blot strips were screened using polyvalent rabbit serum (K1771, panel 1) and the hybridoma 
supernatant 32F71 (anti 25 kDa, panel 2). 
seen when the control sample (0 mM periodate; closed bars) is compared with the treated 
sample (10 mM periodate; open bars). Trifluoromethanesulfonic acid (TFMS) cleaves most 
of the carbohydrate moiety from the polypeptide backbone, but leaves the first N-linked sugar 
(N-acetylglucosamine) attached to asparagine (1,4). The effect of the TFMS-treatment on the 
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Figure 4. Fluorograph after SDS-PAGE of 3SS-methionine-, 3H-palmitic acid- and 3H-myristic acid-labelled 
macrogamete/zygote proteins, before and after 0.1 M КОН hydrolysis. 
Lane 1: total 35S-methionine labelled proteins; lane 2: same as lane 1 after treament with 0.1 M КОН/20% 
methanol; lane 3: total 3H-palmitic acid labelled proteins; lane 4: same as lane 3 after treatment with 0.1 M 
KOH/20% methanol; lane 5: total 3H-myristic acid labelled proteins; lane 6: same as lane 5 after treatment with 
0.1 M KOH/20% methanol. Standard proteins were as in Figure 1. 
immunological reactivity of the 25-kDa protein is shown in Figure 3B. After cleavage of the 
carbohydrate moiety, the molecular weight of the 25-kDa protein is reduced (approx. 23-24-
kDa), as can been seen in the figure (panel 1 and panel 2, lane b). Nevertheless, the mab 
32F71 (non-blocker; panel 2 lane b) and the polyvalent rabbit serum K1771 (panel 1, lane 
b) still react with the deglycosylated protein. Identical results were obtained with the blocking 
mab 32F81 (data not shown). 
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Figure 5. Effect of mild alkali hydrolysis on the 
immunoreactivity of the 25 kDa protein. Western 
blot strips, with the control sample (lanes a) and 
the hydrolyzed sample (lanes b), were screened 
with the hybridoma supernatant 32F71 (panel 1), 
32F81 (panel 2), 32F5 (panel 3) and the 
polyvalent rabbit serum KI771 (panel 4). The 25 
kDa and 45/48 kDa protein positions are 
indicated by arrows. 
Deacylation 
Hydrolysis of the acyl moiety bound to the 25-kDa protein was performed with 0.1 
M КОН in 20% methanol on 35S-methionine-, 3H-palmitic acid- or 3H-myristic acid-labelled 
macro- gametes/zygotes. Figure 4 shows the fluorograph of the SDS-PAGE pattern of the 
non-treated samples (lanes 1, 3 and 5) and the hydrolysed samples (lanes 2, 4 and 6) of the 
35S-methionine-, 3H-palmitic acid- and 3H-myristic acid-labelled material respectively. We 
show here that the 25-kDa protein can be labelled with both these fatty acids. After 
hydrolysis, the 3H-palmitic acid label (lane 4) and the 3H-myristic label (lane 6) were no 
longer detectable. The free labelled fatty acids were removed during the dialysis step. This 
indicates that the fatty acid label was released from the polypeptide backbone. The 
polypeptide backbone is apparently also affected by treatment with KOH. However, 
35S-methionine label is still detectable at the 25-kDa protein position after hydrolysis (lane 
2). In order to investigate the immunological reactivity of the protein after the methanolic 
alkaline treatment, non-labelled proteins were blotted onto nitrocellulose paper and tested 
with the transmission blocking and non-blocking mabs. Figure 5 shows the reaction of the 
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untreated samples (lanes a) and the hydrolyzed samples (lanes b), with three different mabs 
and the transmission blocking polyvalent rabbit serum К 1771. After hydrolysis of the fatty 
acid, the mabs 32F71 (panel 1) and 32F81 (panel 2) do not recognize the 25-kDa protein. 
However, the mab 32F3 (anti 45/48-kDa) binds with equal affinity to the 45/48-kDa proteins 
in both the untreated and hydrolyzed samples, indicating that the polypeptide backbone of 
these proteins is unaffected by KOH treatment. Moreover, the polyvalent rabbit serum K1771 
(panel 4) reacts with the 25-kDa and 45/48-kDa proteins both before and after KOH 
treatment, thus confirming the presence of the proteins on both blots. 
DISCUSSION 
In this study we describe the characterizaton of the major epitopes on the 25-kDa 
protein, with regard to the contributions of (1) the tertiary structure, (2) glycosylation and 
(3) acylation to the structure of these epitopes. 
1. Tertiary structure 
It is generally accepted that the reduction of a protein will cause a loss of the 
secondary and tertiairy structure of the polypeptide, whereby the biological activity and (in 
the case of conformational epitopes) the immunological reactivity of the protein is also lost. 
Reoxidation of the reduced protein under suitable conditions may restore the native 
conformation and consequently the biological activity and immunological reactivity. But 
when, after reduction, the free SH-groups are blocked, the protein is unable to fold back into 
its native conformation and the activity is not restored (22). We have demonstrated that the 
immunological reactivity of the 25-kDa protein is indeed lost after denaturation, reduction 
and carboxymethylation (Fig. 1, 2 and Table 1). These results indicate that the epitopes 
recognized by the blocking and the non-blocking anti-25-kDa mabs are secondary or tertiary 
structural elements of the 25-kDa protein. However, after denaturation, reduction and 
subsequent renaturation, the immunological reactivity of the 25-kDa protein was not restored. 
This indicates that once the original disulphide bonds are cleaved, this protein - in contrast 
to others - cannot regenerate its native conformation. Even when the renaturation of the 
denatured and reduced protein extract took place in a high concentration of detergent (e.g. 
Triton X-114), so as to mimic the original hydrophobic environment of the 25-kDa protein, 
we were unable to restore its immunological reactivity (data not shown). The comparable 
data obtained by immunoprecipitation of radiolabelled proteins, ELISA and Western blotting, 
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clearly show that the immunological inactivation of the 25-kDa protein is caused by the 
reduction event with DTT and that it is not influenced by the type of denaturing agent that 
has been used. These results indicate that the two major epitopes on the 25-kDa protein 
(including the epitope involved in transmission blocking immunity) are conformational and 
completely dependent on the presence of the original disulphide bonds. 
2. Glycosylation 
In contrast to other glycoproteins of parasite origin (13,14), the immunological 
reactivity of the 25-kDa protein is not carbohydrate-dependent. The reactions of the 
transmission blocking and non-blocking mabs and the polyvalent sera were not influenced by 
modification or cleavage of the carbohydrate moiety of the protein (Fig.3). These results 
indicate that the carbohydrate moiety does not form an integral part of the known epitopes 
and does not contribute to the stability and maintenance of these epitopes. 
3. Acylation 
Previous studies have demonstrated that the 25-kDa protein is posttranslationally 
modified with palmitic acid (21). During the present study, it was shown that this protein 
could also be labelled by 3H-myristic acid. The 3H-labelled fatty acid moieties could be 
released by mild alkali treatment, indicating that the fatty acids are covalently linked to the 
protein. This type of posttranslational modification, i.e. the covalent binding of fatty acids 
via ester (serine, OH-group) or thio-ester (cysteine, SH-group) bonds, has been described for 
the analogous protein PGO-1 and the protein PGO-2 of P.gallinaceum (10). This has also 
been observed for many other bacterial, viral and mammalian glycoproteins (15,18). 
However, it is very unusual for myristic acid to be bound to proteins via ester or thio-ester 
linkages (18) and it is possible that the myristic acid (or the palmitic acid) is a component 
of a diacylglyceride linked to the protein via a glycosyl-phosphatidyl inositol bond. The fatty 
acid is therefore not directly esterified to an amino acid residue on the polypeptide backbone 
(8). In this case the fatty acid (myristic or palmitic acid) should be released by enzymatic 
cleavage with a phosphatidyl-inositol-specific phospholipase С (type III from B. cereus) as 
has been described for several proteins including a merozoite protein of P.falciparum (5,6,8). 
However, the 3H-myristic acid label was not released from the 25-kDa protein by 
phospholipase С (data not shown), indicating that a phosphodiester linkage is not involved 
in the binding of the myristic acid label to the protein. But this is not supported by the 
amino-acid sequence as recently deduced by Kaslow et al. (9). Especially the sequence of the 
C-terminus indicates that the protein may have a phosphatidyl-inositol membrane anchor. It 
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is also uncertain whether the myristic acid label is metabolically altered during incorporation. 
Therefore, further experiments are required to determine the identity of all fatty acids bound 
to the 25-kDa protein, and the nature of the linkages involved. The contribution of the fatty 
acids to the structure of the major epitopes on the 25-kDa protein was determined on Western 
blots. Certain epitopes on this protein, including the epitope involved in transmission 
blocking immunity, were shown to be dependent on the presence of the fatty acid chains. 
However, the polyvalent rabbit serum still reacts with the protein after deacylation (Fig. 5). 
This indicates the existence of other, unknown epitopes on the 25-kDa protein whose 
reactivity with antibodies is unaffected by the presence or absence of fatty acids. It cannot 
be stated as yet whether the acyl moieties form an integral part of the acyl-dependent 
epitopes, since the acyl moieties may induce and stabilize particular conformations of the 25-
kDa protein recognized by the blocking and non-blocking mabs. The biological function of 
the 25-kDa protein is not known. Studies on protein acylation have suggested that the binding 
of fatty acids to proteins facilitates lipid bilayer interaction, or has a function in membrane 
fusion events (15). It is tempting to speculate that the 25-kDa protein may be involved in one 
or both of these events. This might explain how monoclonal antibodies against the 25-kDa 
protein damage the transitional stage of ookinetes - and directly block the further 
development of the malaria parasite (ookinete) - effectively. With regard to the cloning of 
the gene encoding for the 25-kDa protein, these findings underline the difficulties that have 
been encountered with the use of immunological probes. Recently, the gene has been cloned, 
but by using oligonucleotide probes based on peptide sequences (9). The structure of the 
protein from the deduced amino-acid sequence is consistent with the findings described here. 
The deduced amino-acid sequence in combination with the knowledge about the structure of 
the protein, with regard to its posttranslational modifications, may contribute to the 
development of a transmission blocking malaria vaccine. 
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APPENDIX TO CHAPTER 3 
The identity of all fatty acids covalently linked to proteins (especially the 25-kDa 
protein) of macrogametes/zygotes were determined. Briefly, macrogametes/zygotes were 
solubilized and the membrane lipids were separated from the extracted lipoproteins by 
chloroform/methanol extraction (1). The covalently linked fatty acids were released and 
transmethylated with HCl/methanol, extracted into hexane and analyzed by capillary gas 
chromatography (2). 
In the total protein extract, palmitic acid (CI6:0) was the shortest fatty acid which was 
identified. This was confirmed by mass spectrometry. The ratios of the fatty acids identified 
are given in Table 1. Four types of fatty acids could be determined of which palmitic acid 
is the most abundant. 
Table 1. The prcentage of different falty acids covalently bound to proteins from 
macrogametes/zygotes as analyzed by capillary gaschromatography. 
Fatty acid 
Palmitic acid (C16:0) 
Steanc acid (C18:0) 
Linoleic acid (C18.2) 
Arachidonic acid (C20.4) 
% covalently bound" 
44 ± 8 
15 ± 4 
23 ± 10 
11 ± 5 
'percentages are given as mean values ± S E 
Standard deviations are from six different samples. 
During metabolic radiolabelling with 3H-palmitic acid (C16:0) or 3H-myristic acid (C14:0), 
approximately 50% of the radiolabel becomes covalently bound to the 25-kDa protein. The 
labelling with 3H-palmitic acid and 3H-myristic acid are equally efficient. Since no myristic 
acid is identified in the described analysis, it is tempting to speculate that the parasite has an 
intrinsic pool, with metabolites, where the myristic acid is elongated with two (or more) C-
atoms before it is covalently bound to the 25-kDa protein. The elongation of the myristic acid 
into palmitic acid (stearic acid, linohc acid or arachidonic acid) could also explain the 
relatively easy release of the fatty acid by mild alkali after 3H-myristic acid labelling. 
However, the identity of the covalently linked fatty acids does not have any implications for 
the nature of linkage of fatty acids to this protein. Therefore, further experiments are 
required to obtain information about the nature of the linkage involved. 
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CHAPTER 4 
INVOLVEMENT OF С ARBOHYDRATEMOEETIES IN MONOCLONAL ANTIBODY 
RECOGNITION OF THE 45/48-kDa PROTEINS FROM GAMETOCYTES OF 
PLASMODIUM FALCIPARUM 

INTRODUCTION 
The sexual stage-specific proteins of P.falciparwn with a molecular weight of 45-kDa 
and 48-kDa are target antigens for transmission blocking antibodies. Therefore, the 45-kDa 
and 48-kDa proteins are important proteins in the development of a transmission blocking 
vaccine. In addition, these proteins are already present in the gametocytes, and human 
antibodies against the 45-kDa and 48-kDa protein have been detected (2,10; Beckers et al. 
unpublished results). 
The 45-kDa and 48-kDa proteins are synthesized in the gametocytes and are later 
expressed on the surface of newly emerged macrogametes (7,8). The two proteins have 
similar characteristics: both proteins are posttranslationally modified by glycosylation, have 
an iso-electric point of 6.0 ± 0 . 1 and are recognized by the same set of monoclonal 
antibodies (8). 
With respect to the development of a transmission blocking vaccine, it is important 
to establish whether the carbohydrate moieties, an amino acid sequence or their combination 
are involved in the epitope recognition. To assess the contribution of the carbohydrate groups 
to the epitopes on the 45-kDa and 48-kDa proteins, the immunological reactivity of the 
proteins was tested after (i) modification, (ii) enzymatic cleavage and (iii) modification and 
enzymatic cleavage of the carbohydrate moieties. 
MATERIALS AND METHODS 
Parasites 
Mature gametocytes of P.falciparwn (isolate NF 54) were produced in a semi-
automated culture system as described by Ponnudurai et al. (3). Gametogenesis was induced 
by incubating the mature gametocytes in fetal calf serum (FCS) at room temperature for 30 
min. Macrogametes/zygotes were purified as described by Vermeulen et al. (7). 
Solubilization 
Purified gametocytes or macrogametes/zygotes were solubilized in 25 mM Tris-HCl 
(pH 8.0) containing 0.5% Nonidet P-40 and 1 mM Phenylmethylsulfonylfluoride for 30 min 
at room temperature. After centrifugation for 15 min at 18000 g, the sediment was discarded 
and the soluble protein stored at -20oC until use. 
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Monoclonal antibodies 
Monoclonal antibodies (mabs) produced against the surface proteins of P.falciparum 
macrogametes/zygotes (7) were used in this study. Protein-A purified mabs 32F1 (anti 45/48-
kDa, transmission non-blocking) and 32F5 or 32F3 (anti 45/48-kDa, transmission blocking) 
were used in the modified two-site ELISA as described below. 
Periodate oxidation 
The periodate oxidation was carried out in combination with a two-site ELISA as 
described by Fries et al. (1). Protein extracts of both gametocytes and macrogametes/zygotes 
were used. Bound proteins were exposed to different concentrations of periodate (0, 5, 10, 
15 and 20 mM). Either 32F1 or 32F3/32F5 was used to coat microliter plates in order to 
capture the 45/48-kDa protein, via their 'single' specific epitope. For the detection of bound, 
immunologically reactive proteins, biotinylated 32F3/32F5 (with 32Fl-coating) and 
biotinylated 32F1 (with 32F3/32F5-coating) was used. 
Enzymatic cleavage with Peptide:N-glycosidase F (PNGase F) 
The enzymatic cleavage was performed by PNGase F in combination with a two-site 
ELISA. Mabs and proteins were coated and captured as described by Fries et al. (1). The 
plates were washed with SPP (0.25 M sodiumphosphate (pH 7.8); 10 mM 1,10 
phenanthroline). Bound proteins were exposed to 1.5 units/ml PNGase F in SPP for 18 h 
at 370C. (The plates were sealed to inhibit evaporization.) After two washings with SPP, 
the plates were incubated with 1 % glycine in PBS for 30 min (in order to provide identical 
circumstances in all experiments) and the ELISA was further completed as described 
(l;Ch. 3). 
The periodate oxidation and the PNGase F cleavage were also combined in an experiment. 
The periodate oxidation was performed without the blocking step (1 % Glycine/PBS) and 
followed by cleavage with PNGase F. After incubation with 1% Glycine/PBS, the two-site 
ELISA was completed. 
RESULTS 
Modification of the carbohydrate moiety 
The effect of the modification of the carbohydrate moiety by periodate oxidation on 
the reactivity of the 45-kDa and 48-kDa protein with the transmission blocking (B: 32F5) and 
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Figure 1. Effect of penodate oxidation of the 45-kDa and 48-kDa protein on the binding of transmission 
blocking and non-blocking monoclonal antibodies. The still present immunological reactivity (measured OD 450 
nm) is given as a percentage of the OD measured at 450 nm with respect to the control. 
B: 32F3, blocking mab; NB 32F1, non-blocking mab 
Treated samples (5, 10, 15 and 20 mM penodate) were compared with the control sample (0 mM) 
the non-blocking (NB: 32F1) mabs, was assessed by two-site ELISA (Fig. 1). Penodate 
oxidation was performed at different concentrations of penodate (0-20 mM) for 1 h in the 
dark. The upper limit was 20 mM periodate, otherwise the protein backbone might also have 
been affected (9). A significant decrease of immunological reactivity for both mabs was 
observed, although the immunological reactivity was not totally destroyed even after 
incubation with 20 mM periodate. The modification of the carbohydrate groups had more 
effect on the non-blocking than on the blocking epitope. 
Enzymatic cleavage of the carbohydrate moiety 
Enzymatic cleavage of the carbohydrate moiety was performed with Peptide: N-
Glycosidase F (PNGase F). PNGase F hydrolyses N-linked oligosaccharides at the innermost 
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the carbohydrate groups from the 45-kDa and 48-kDa 
proteins on the binding of transmission blocking and non-
blocking monoclonal antibodies. 
B: 32F3, blocking mab; NB: 32F1, non-blocking mab. control в NB 
glycosylamine and generates a carbohydrate-free peptide and an intact oligosaccharide (6). 
The advantage of this enzyme is the fact that proteins in their native conformation are also 
susceptible for PNGase F (although a greater amount of enzyme is needed than after 
reduction of the protein). Therefore, PNGase F could be used for deglycosylation of the 45-
kDa and 48-kDa protein in combination with a two-site ELISA. The 45-kDa and 48-kDa 
protein, captured in mab coated wells of a PVC-plate, was incubated with an excess of 
PNGase F (1.5 units/ml) for 18 h at 370C. These conditions were chosen to ensure complete 
removal of carbohydrate from the native protein. The effect of deglycosylation with PNGase 
F is shown in Figure 2. A significant decrease of immunological reactivity for both mabs was 
observed, and the effect is more pronounced for the reactivity of the non-blocking epitope 
than of the blocking epitope. However, cleavage of the carbohydrate moiety does not 
completely suppress the immunological reactivity of the proteins, similar to the behaviour 
upon treatment with periodate. 
A possible reason for the remaining immunological reactivity of the 45-kDa and 48-
kDa protein could have been an incomplete removal of the carbohydrate. Therefore, 
modification (by periodate) and enzymatic cleavage (by PNGase F) were performed in one 
experiment in order to diminish the immunological reactivity. The effect of the combined 
modification and cleavage on the immunological reactivity of the 45-kDa and 48-kDa protein 
is given in Figure 3. Periodate was used in three different concentrations (0, 10 and 20 mM) 
and PNGase F was used in one concentration (1.5 units/ml). In case of the blocking epitope, 
the combination of periodate and PNGase F resulted in a further decrease of the 
immunological reactivity. However, both epitopes were also not totally destroyed in this 
in 
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Figure 3. Effect of the combination of periodate oxidation and enzymatic cleavage (PNGase F) of the 45-kDa 
and 48-kDa proteins on the binding of transmission blocking and non-blocking monoclonal antibodies. 
Control: 0 mM periodate, no PNGase F; B: 32F3, blocking mab; NB: 32F1, non-blocking mab. 
experiment. With 0 mM periodate and 1.5 units/ml PNGase F (only deglycosylation), the 
non-blocking epitope was more affected than the blocking epitope. 
DISCUSSION 
The contribution of the carbohydrate moiety to the structure of the major epitopes on 
the 45-kDa and 48-kDa proteins was investigated by modification and enzymatic cleavage of 
the carbohydrate moiety. Since the effect was measured in a two-site ELISA, no distinction 
between the 45-kDa and 48-kDa protein reactivity was possible. 
Although the immunological reactivity of the epitopes of the 45-kDa and 48-kDa protein, 
including the epitope involved in transmission blocking immunity, decreased after 
modification or cleavage of the carbohydrate group, their reactivity was never totally 
eliminated. The combination of the modification and enzymatic cleavage of the carbohydrate 
moieties resulted in a further decrease of immunological reactivity with regard to the 
blocking epitope, but a small part (approx. 10%) of the epitopes of the 45-kDa and 48-kDa 
protein remained reactive. 
The remaining immunological reactivity could be the result of incomplete modification 
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or cleavage of the carbohydrate moiety. In order to obtain information on the presence or 
absence of intact oligo-saccharides, reactions with lectines were performed. Three lectines 
(Concavalin A, Triticum vulgaris, Bandeireae simplicifolia 1) which recognize different sugar 
groups, were used to detect the carbohydrate on the intact 45-kDa and 48-kDa protein. 
However, these three lectines appeared to react not or very weakly with the proteins (data 
not shown). Therefore, it was impossible to rule out that the remaining immunological 
reactivity still was due to incomplete modification or cleavage. 
However, these results would indicate that the carbohydrate moiety is not an integral 
part of both epitopes, if it could be assumed that its modification and the enzymatic cleavage 
had been complete. In that case, the contribution of the carbohydrate is more likely to be 
inducing, stabilizing and maintaining the conformation of adjacent parts of the polypeptide 
chain. The carbohydrate may force the proteins into a particular conformation essential for 
the expression of certain epitopes as is suggested to occur in P.falapanm merozoite 
glycoproteins (4,5). The results presented additionally indicate that the contribution of the 
carbohydrate group to the structure of the epitope is more pronounced for the non-blocking 
epitope than for the blocking one. 
More information on the involvement of the carbohydrate moieties in the expression 
of the epitopes (including the epitope involved in transmission blocking immunity) of the 45-
kDa and 48-kDa protein cannot be obtained with the small amount of available protein used 
in these techniques. With larger quantities of isolated 45/48-kDa protein, the same 
experiments should be repeated and extended with SDS-PAGE in order to obtain unequivocal 
results. 
Nevertheless, the observations reported here may provide an explanation for the difficulties 
which have been encountered with the immunological screening of P.falciparum cDNA-
expression libraries in E.coli. 
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CHAPTER 5 
A PRACTICAL APPROACH FOR THE ISOLATION AND PURIFICATION OF 
MEMBRANE PROTEINS FROM SEXUAL STAGES OF PLASMODIUM 
FALCIPARUM. 
Hella C.W. Fries, Marieke B.A.C. Lamers 

INTRODUCTION 
Transmission of Plasmodium falciparum can be blocked by polyclonal and monoclonal 
antibodies against sexual stage specific antigens (10,11). The P.falciparum target antigens 
were shown to be present on the surface of freshly emerged macrogametes (Mr 230-kDa and 
Mr 45/48-kDa) and developing ookinetes (Mr 25-kDa). These target antigens are important 
proteins in the development of a transmission blocking vaccine. Since such a vaccine will be 
based on recombinant DNA-technology or synthetic peptide-technology, the first step in the 
development of this vaccine will be the cloning of the genes encoding for these antigens. 
However, it was impossible to select clones from P.falciparum genomic- and cDNA-libraries 
in Escherichia coli with immunological probes, because the immunodominant B-cell epitopes 
on the 25-kDa and 45/48-kDa proteins are conformation-dependent (3,ll,Ch.4). 
In order to clone the genes encoding the sexual stage-specific proteins another strategy 
has to be followed. A different approach is screening P.falciparum genomic- and cDNA-
libraries with oligonucleotide probes derived from amino acid sequences of the protein. 
Therefore, we developed a protocol for the isolation and purification of these antigens, 
primarily for the 25-kDa protein. Meanwhile Kaslow et al. (4) designed a comparable 
protocol for the isolation and purification of the same protein. The differences between these 
protocols will be discussed. 
MATERIALS AND METHODS 
Parasites 
Mature gametocytes of P.falciparum (isolate NF 54) were produced in an automated 
large-scale culture system as described by Ponnudurai et al. (9). Gametogenesis was induced 
by incubating the mature gametocytes in fetal calf serum (FCS) at room temperature for 30 
min. Macrogametes were purified as described by Vermeulen et al. (11). 
Biosynthetic labelling of parasite proteins with 35S-methionine was performed as described 
by Fries et al. (3). 
Monoclonal antibodies 
Monoclonal antibodies (mabs) produced against the surface proteins of P.falciparum 
macrogametes/zygotes (11) were used in this study. The hybridoma supernatant or Protein 
A purified mabs 32F61 and 32F81 (anti 25-kDa, transmission blocking), and mabs 32F71 
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and 32F72 (anti 25-kDa, transmission non-blocking) were used in the different techniques 
as indicated. 
Triton X-114 solubilization and phase separation 
Triton X-114 (TX-114) was precondensed as described by Bordier (1) and used as a 
10% (w/v) stock solution. Macrogametes/zygotes were solubilized in 2% TX-114 in a Tris-
HC1 buffer (10 mM Tris-HCl, 150 mM NaCl (pH 7.4) with 1 mM phenylmethylsulfonyl-
fluoride (PMSF) at 40C for 90 min. Insoluble material was removed by centrifugation at 
40.000 rpm for 60 min at 0-4oC. Supematants were collected in tubes on ice using prechilled 
pasteur pipettes. Phase separation was carried out by warming the supernatant for 15 min at 
370C. Centrifugation, 10 min at 2500 rpm at room temperature, resulted in the aqueous 
upper phase (Wl) and the detergent lower phase (Dl). After separation of the aqueous phase 
from the detergent phase, TX-114 (10% stock) was added to the aqueous phase Wl to a final 
concentration of 2% TX-114. To repeat phase separation, Wl was incubated for 10 min on 
ice, rewarmed and centrifuged as described above. The resulting aqueous phase (Wl A) was 
separated from the detergent phase (DW1). The detergent phases Dl and DW1 were 
combined and redissolved in 4 volumes Tris-HCl buffer by incubating for 10 min on ice. 
Phase separation (as above) gave the detergent phase D2, and the aqueous phase was 
discarded. The phase separation was repeated once more and resulted in the detergent phase 
D3. The aqueous and detergent phases were tested in the two-site ELISA and analyzed on 
SDS-PAGE after each step. 
Immuno-affinity chromatography (IAC) 
Each monoclonal antibody used for the preparation of an immuno-column was purified 
by Protein-A (7). The purified mab was coupled to CNBr-activated Sepharose 4B 
(Pharmacia) according to the manufacturer's instructions. The coupling efficiency was about 
95%, as determined by OD measurements at 280 nm. The affinity column was stored in 
phosphate buffered saline (PBS) with 0.1 % sodium azide. 
The specific immuno-affinity column was used as a batch absorbent. Prior to use the 
immuno-beads (ca. 10 ml.) were washed with PBS and with wash buffer (50 mM Tris-HCl 
(pH 8.0); 150 mM NaCl). 
The detergent phase D3 was diluted to a volume of 30-40 ml with wash buffer, applied to 
the immuno-matrix and incubated by gentle agitation for 16-24 hours at 4CC. The sepharose 
beads and supernatant were separated by gentle centrifugation (1000 rpm, 2 min). The excess 
of TX-114 was removed by incubating the immuno-column with wash buffer for 30 min at 
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4 0C. The beads and supernatant were again separated by centrifugation. The beads were 
resuspended in approximately 30 ml wash buffer and poured into a column. The column was 
then washed once more with wash buffer. 
Antigens specifically bound to the column were eluted from the beads with 3 column volumes 
of 50 mM diethylamine (DEA; pH 10.5), containing 0.2 % ZW3-12 (or with another elution 
buffer as indicated in Table 2). Fractions of 1 ml were collected and immediately neutralized 
by the addition of 1/10 volume of 50 mM sodium dihydrogen phosphate. After dialysis 
against aqua bidest, followed by dialysis against 0.02% trifluoroacetic acid (in order to create 
an acetic environment and keep the proteins soluble), the detergent was removed by 
incubation with Bio-Beads (sm-2, Biorad) for 1 hour at room temperature. The fractions 
collected were identified with the two-site ELISA and with SDS-PAGE, and fractions 
containing the 25-kDa protein were pooled. 
Reversed-phase FPLC (RPC) 
Reversed phase chromatography was performed with a C1/C8 column (Pharmacia). 
Samples eluted from the immuno-affinity column, containing the 25-kDa protein, were 
chromatographed at a flow rate of 0.2 ml/min with a continuous gradient from 10 to 60% 
solvent В in solvent A, during 25 ml and from 60 to 100% during 1 ml. 
Solvent A was 0.25% trifluoroacetic acid (TFA) and solvent В was 0.1 % TEA in ethanol-1-
butanol (4:l,v/v). Protein absorption was measured at 214 nm and fractions of 0.5 ml were 
collected. After evaporation of the organic solvents in a Speedvac (Dumee), the fractions 
were identified with the two-site ELISA and with SDS-PAGE. 
Miscellaneous methods 
Detergent (NP-40/ZW3-12) was removed with Bio-beads (sm-2) as described by van 
der Zee et al. (14). Reduction of the proteins was carried out with 20 mM dithiothreitol (final 
concentration). SDS gel electrophoresis was performed according to Laemmli (6) or on Phast 
system with 10-15% acrylamide gels (Pharmacia), and silver staining of the protein bands 
according to Wray et al. (13). Immunoblotting and the two-site ELISA was performed as 
described by Fries et al. (3). 
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RESULTS AND DISCUSSION 
The development of an isolation and purification procedure for the 25-kDa protein has 
been hindered by many problems. A limited amount of available parasites, formation of large 
aggregates and the loss of immunological reactivity after reduction were the major problems. 
The limited amount of starting material had consequences for the detection of the 25-kDa 
protein throughout the isolation procedure. Despite the disadvantage of the two-site ELISA 
i.e. its dependency on the presence of immunologically active protein, the two-site ELISA 
was used to detect the 25-kDa protein throughout the procedure. Furthermore, the isolation 
procedure had to be performed with a minimum amount of 500 million parasites, i.e. about 
half the amount of a two weekly's large scale parasite culture. 
Chromatofocusing and gelfiltration chromatography have been used in order to obtain 
an enriched 25-kDa protein fraction from the crude extract. However, with these techniques 
it was impossible to achieve a separation of protein fractions due to the formation of 
aggregates of membrane proteins during solubilization with Nonidet P-40 or Zwitterion 3-12 
(data not shown). 
To overcome the problem of aggregate formation, the Triton X-114 (TX-114) 
solubilization procedure as described by Bordier (1) was carried out. The advantage of the 
TX-114 solubilization procedure is the separation of the hydrophobic proteins, -i.e. mostly 
amphiphilic integral membrane proteins-, from the hydrophilic proteins by phase separation. 
Furthermore, the 25-kDa protein was obtained in a relatively small volume. 
Table 1. Results of the two-site ELISA for the detection of the 25 kD protein in different TX-114 
solubilization and phase separation steps as described in materials and methods. 
Total extract 
Pellet (insoluble material) 
Aquous phase (W) 
Detergent phase 
-after one wash step: Wl 
DW1 
Solubilization/Phase separation" 
S PI 
+ 
-
+ 
+ 
Pia 
-
+ 
P2 P3 
ND 
+ + 
" S: solubilzation; P: phase separation; 
+ : positive reaction; -: negative reaction; ND: not done. 
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Mr 
(X IO3) 
97 -
43 
31 
14 -
Figure 1. SDS-PAGE (lanes 1-3) and Western blotting (lanes 4-6) of protein samples taken during the TX-114 
solubilization and phase separation procedure as described in materials and methods. 
Protein bands on the SDS-gel were visualized by silver staining and the Western blot was screened using the 
hybridoma supernatant 32F71 (anti 25-kDa). 
Lane 1: standard proteins: ß-galactosidase (Mr 116,000), Phosphorylase В (Mr 97,000), bovine serum albumin 
(Mr 66,000), ovalbumin (Mr 43,000), carbonic anhydrase (Mr 31,000), soybean trypsin inhibitor (Mr 21,500), 
α-lactalbumin (Mr 14,000); lanes 2 and S: aqueous phase; lanes 3 and 6: detergent phase; lane 4: total extract 
of macrogamete/zygotes protems. 
Triton X-114 solubilization and phase separation 
After solubilization of the parasite proteins in 2 % TX-114, three phases were obtained 
by ultracentrifugation (insoluble pellet) and phase separation (the aqueous and the detergent 
phase). These three phases were tested for the presence of the 25-kDa protein in the two-site 
ELISA (Table 1). After the solubilization procedure there was no detectable amount of 
25-kDa protein left in the insoluble pellet. Three cycles of phase separation were enough to 
complete the partitioning of the 25-kDa protein, without considerable losses, in the detergent 
phase. The aqueous phase Wla and the detergent phase D3 were also analyzed on SDS-
PAGE. Figure 1 shows the distribution of the solubilized proteins in the aqueous and 
detergent phase. Although the sample with the total extract shows no clear band at a Mr of 
25,000 it is distinctive in the detergent phase D3 (Fig. 1, lane 3). Western blotting of the 
aqueous phase Wla and the detergent phase D3 also demonstrated that the 25-kDa protein 
was absent in the aqueous phase and completely partitioned in the detergent phase 
respectively (Fig. 1, lane 5 and 6). The TX-114 solubilization of the similar protein (31/34-
kDa) of the other plasmodial species P.gallinaceum showed also a complete partitioning of 
this protein in the detergent phase (5). This solubilization is the first step of the procedure 
for the isolation and purification of the 25-kDa membrane protein. 
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Table 2. Immuno-affmtiy chromatography of the 25 kDa protein. Comparison of different elution buffers 
and detergents. 
Elution buffers 
50niM DEA pH 10,5 
+ 0,2% ZW3-12" 
+ 0,2% CHAPS" 
+ 0,5% DOC" 
lOOmM Glycme-
HC1 pH 2,8 
+ 0,2% ZW3-12* 
Immunological reactivity" 
before 
dialysis 
+ + 
+ + 
+ 
+ + 
after 
dialysis 
+ bio-beads 
+ + 
+ 
Yield 
after 
dialysis 
90% 
90% 
85-90% 
90% 
after 
bio-beads 
60-70% 
ND 
ND 
60% 
" ZW3-12 : Zwittenonen 3-12 
CHAPS : 3-(3'-cholamidopropyl)dimethylammonio-l-propanesulfonate 
DOC : Sodium Deoxycholate 
~ Measured with the two-site ELISA 
OD«, : + + : OD«, > 1.0; +; 0.Э < OD«, > 1.0; : OD«, < 0.3; -: OD«, <0.1. 
ND: Not Done. 
Inununo-affinity chromatography (IAC) 
After the first separation step, the detergent phase (D3), which was enriched with the 
25-kDa protein, could be used for an immuno-affinity chromatography step. Different mabs, 
32F71/32F72 (the transmission non-blocking mabs) and 32F81/32F61 (the transmission 
blocking mabs) were used as the immobile ligand. All the mabs showed the same binding­
and elution-pattems. When D3 was applied to the column, practically all the 25-kDa protein 
was bound. To control the binding capacity of the immuno-column, the eluted washing 
buffers were analyzed in the two-site ELISA to detect unbound 25-kDa protein. 
To release the bound protein from the immuno-affinity column, the elution buffers 
diethylamine (DEA; pH 10.5) and glycine-HCl (pH 2.8) and the detergents ZW3-12, CHAPS 
and sodium deoxycholate (DOC) (see Table 2) were tested. The 25-kDa protein could be 
totally eluted from the immunoaffinity column by each of the three elution procedures. A 
typical SDS-PAGE pattern is shown in Figure 2. The yield of the 25-kDa protein was always 
about 80-90%, as measured in the two-site ELISA directly after elution. When CHAPS or 
DOC was used as the detergent, dialysis in order to remove the elution buffer and these 
detergents, resulted often in an immunological non-reactive protein (Table 2). Although the 
25-kDa protein could be detected by silver staining (after IAC) in most experiments, the two-
site ELISA remained a rapid and simple assay for the detection of the protein. Therefore, 
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Figure 2. SDS-PAGE (lanes ш, 1-3) and Western blotting (lanes 4-5) of immuno-affinity chromatography 
eluates. Protein bands on SDS-PAGE were visualized by Coomassie Brilliant Blue staining and the Western 
blots were screened using the hybridoma supernatant 32F71 (anti 25-kDa) and/or rabbit-anti-mouse IgG (RAM). 
Lane m: standard proteins (as in figure 1); lane 1: proteins eluted with 0.2% ZW3-12; lane 2: proteins eluted 
with 0.5% CHAPS; lane 3: proteins eluted with 0.5% DOC; lane 4: proteins eluted with 0.2% ZW3-12, the 
blot was screened with RAM; lane 5; proteins eluted with 0.2% ZW3-12, the blot was screened with 32F71 
and RAM. The 25-kDa protein is indicated by an arrow. 
the combination of 50 mM DEA (pH 10.5) with ZW3-12, was used as the elution buffer in 
I AC. As can been seen in Figure 2 (lane 1-3,5), more proteins were eluted from the 
immuno-affinity column. The two most heavily stained protein bands are the heavy and light 
chain of the mab IgG, as demonstrated on a western blot (Fig. 2, lane 4) screened with RAM 
(rabbit anti mouse antibodies). These proteins were present in the eluted fractions, due to 
leakage of IgG from the affinity column. The reason for this leakage is yet unknown. 
For proper amino acid sequence determinations, the IgG portion in this fraction and 
the detergent have to be removed from the 25-kDa containing fraction. So, an additional 
purification step was performed by reversed-phase chromatography. 
Rcversed-phase chromatography (RFC) 
The technique of RFC is based on the hydrophobic interaction of proteins with the 
stationary ligand (12). Proteins unfold, precipitate and dissolve during the chromatography. 
The organic solvent is therefore an important factor, since these events probably co-
determine the retention behaviour of the proteins (12). Two different organic solvent systems 
were compared: acetonitrile, the most frequently used and recommended organic solvent 
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Figure 3. 
Α. Elution profile of the protein sample, 
obtained by immuno-affinity chromatography. 
The proteins were fractionated by RP-FPLC 
on a C1/C8 colunm with a discontinuous 
gradient of ethanol-1-butanol (10-60%) in 
0.1 % trifluoroacetic acid as indicated in the 
figure (%B). The absorbance was monitored 
at 280 nm (A»). 
B. Silver-stained SDS-gel. Lane m: standard 
proteins (as in figure 1); lane 2a, 2b, 2c 
correspond with the peak fractions 2a, 2b, 2c 
as indicated in figure ЗА. 
C. Two-site ELISA: the measured OD 4S0nm 
was plotted against each peak fraction (legend 
numbers correspond with peak numbers). 
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Figure 4. Elulion profile of the protein sample, obtained by immuno-aflinity chromatography and treated with 
Bio-beads sm-2. The proteins were fractionated by RP-FPLC on a C1/C8 column with a discontinuous gradient 
of ethanol-1-butano! (10-40%) in 0.1 Я trifluoroacetic acid as indicated in the figure (%B). The absorbance was 
monitored at 214 nm (A,,,). 
Insert: silver-stained SDS-PAGE of peak fraction (m; standard proteins). 
system (2), and ethanol- 1-butanol. The ethanol-1-butanol system was used as described by 
van der Zee et al.(14) with minor modifications (see Materials and Methods). 
With acetonitrile as the organic solvent it was impossible to achieve a good 
separation: the 25-kDa protein elutes in more than one peak (data not shown). Furthermore, 
after RFC with acetonitrile, the 25-kDa protein had lost its immunological reactivity and 
consequently the two-site ELISA became useless for the detection of the protein. In contrast, 
the 25-kDa protein remained immunologically reactive after RFC with ethanol-1-butanol as 
the organic solvent. This phenomenon has already been described for some proteins (8). RFC 
with ethanol-1-butanol resulted in the elution of the 25-kDa protein in three small peaks 
(Fig. ЗА), at 30% ethanol-1-butanol (solvent B). The two-site ELISA revealed that the 
protein was present inali three peaks (Fig. 3C), and the results of the SDS-PAGE (Fig. 3B) 
indicated that the separation of the peak was merely caused by the absence or presence of the 
detergent ZW3-12. The 25-kDa protein was not pure since a 60-kDa protein (possibly related 
to mab IgG) and the detergent ZW3-12 eluted at the same time. Therefore, a treatment with 
Bio-beads, in order to remove the detergent, was carried out before the protein sample was 
applied onto the RPC-column. This treatment caused some loss of protein (Table 2), but 
removed the detergent almost completely. The elution pattern of a Bio-beads protein sample 
is shown in Figure 4. At 33 % solvent B, one single peak elutes from the RPC-column, which 
contained the 25-kDa protein (as determined by the two-site ELISA and SDS-PAGE), but 
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Diagram 1. Procedure for the isolation and purification of the 25-kDa 
membrane protein of P.falciparum. 
also the contaminating 60-kDa IgG protein. 
Since, at this stage of our efforts, Kaslow et al. (4) published the amino acid sequence 
of the 25-kDa protein, a further continuation of these laborious procedures seemed no longer 
meaningful and therefore this line of our research was suspended. There are some differences 
between the protocol used by Kaslow et al. and the protocol described here (Diagram 1). The 
most important difference is the use of TX-114 solubilization and phase separation (in order 
to prevent aggregation) prior to I AC, while Kaslow et al. used TX-100 for the solubilization 
of the membrane proteins and urea only after I AC. Another difference is the use of RPC for 
the further purification of the 25-kDa protein after IAC. Kaslow et al. used SDS-PAGE to 
separate the contaminating proteins from the 25-kDa protein and eluted the 25-kDa protein 
from the SDS-gel by passive diffusion. 
Since the 25-kDa protein was N-terminally blocked, resisting direct amino acid 
sequencing, Kaslow et al. digested the protein with trypsin to generate new N-termini which 
could be sequenced by automated Edman degradation. The amino acid sequence has been 
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determined by a combination of sequencing tryptic peptides of the 25-kDa protein and 
sequencing of a genomic DNA-fragment, that had been selected by hybridization with an 
oligonucleotide probe based on a tryptic sequence. 
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CHAPTER 6 
ISOLATION AND PURIFICATION OF THE 45/48-kDa SURFACE PROTEIN OF 
PLASMODIUM FALCIPARUM GAMETOCYTES. 
Hella C.W. Fries, Clemens H.M. Koeken, Marieke M.B.A.C. Lamers, John G.G. 
Schoenmakers, Joseph J.H.E.Th. Meuwissen. 

INTRODUCTION 
Previous studies have demonstrated that the 45/48-kDa protein is an important target 
antigen of transmission blocking antibodies on the surface of freshly emerged gametes of 
P.falciparum (8,10). The transmission blocking polyclonal and monoclonal antibodies 
directed against the 45/48-kDa protein have been been used to screen P.falciparum genomic-
and cDNA-expression libraries in E.coli in order to isolate the gene encoding the 45/48-kDa 
protein. However, since the immunodominant epitopes on the 45/48-kDa protein are 
conformation-dependent (10) and possibly also depending on the presence of carbohydrate 
groups (Chapter 4), screening of these libraries was not succesful with immunological 
probes. 
Isolation of the gene encoding the 25-kDa surface protein oí P.falciparum ookinetes, was also 
not succesful using immunological screening methods, due to similar properties of mabs 
directed to the 25-kDa protein. However, Kaslow et al. (3) obtained the gene, encoding the 
25-kDa protein, by screening a gamete cDNA-library with oligonucleotide probes, derived 
from internal amino acid sequences of the 25-kDa protein. Since the N-terminus was blocked 
for N-terminal sequence analysis, enzymatic (trypsine) digestion was necessary in order to 
obtain peptides with suitable N-termini for sequence analysis. 
In this study, we report the results of the purification of the 45/48-kDa protein from 
P.falciparum gametocytes to obtain sequence information of the protein. Since the N-
terminus of the 45/48 kda protein is most likely blocked, trypsin digestion of the purified 
protein was used to generate peptides of the protein with free N-terminal ends. Isolation and 
micro-sequencing of tryptic peptides of the 45-kDa protein and of the 48-kDa protein resulted 
in three internal amino acid sequences. Two of these sequences were suitable as a template 
for the synthesis of redundant oligonucleotide probes, which can be used for the screening 
of P.falciparum genomic- or cDNA-libraries in E.coli. 
MATERIALS AND METHODS 
Parasites 
Gametocytes of P.falciparum (isolate NF 54) were produced in an automated large 
scale-culture system as described by Ponnudurai et al. (7). Gametocytes were purified from 
asexual parasites on 18% Nycodenz solution by centrifugation for 30 min at 6000 X g at 
24eC (11). The non-infected erythrocytes present in the gametocyte fraction, were lysed by 
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incubation in 140 mM Νϋ,Ο for 5 min at 4β<3, followed by centrifugation in an Eppendorf 
centrifuge for 10 min at 4 0C. 
Purification of the gametocyte 45/48-kDa surface protein 
The purification of the gametocyte 45/48-kDa surface protein is essentially a three 
step process. In the first step, gametocyte proteins are solubilized using Triton X-114, and 
hydrofobic, detergent-soluble proteins are separated from hydrofilic, water-soluble proteins. 
In the second step, the 45/48-kDa protein is isolated by immuno-affmity chromatography 
using the monoclonal antibody (mab) 32F5. The eluted protein is further purified in the last 
step by sodium dodecyl sulfate-polyacrylamide gelelectrophoresis (SDS-PAGE). 
1. Detergent extraction. A Triton X-114 extract of 3 x 109 gametocytes was made by 
sonication of the gametocytes in 42 ml 2% (v/v) Triton X-114 (Sigma, St.Louis, MO, 
U.S.A.) in 10 mM Tris-HCl (pH 7.4), 150 mM NaCl, containing the following protease 
inhibitors: phenylmethylsulfonyl fluoride (PMSF, 170 μg/ml), tosyl-phenylalanine 
chloromethyl ketone (TPCK, 100 /xg/ml), tosyl-lysine chloromethyl ketone (TLCK, 50 
/ig/ml), pepstatin (0.7 Mg/ml), and leupeptin (0.5 ftg/ml). The suspension was incubated on 
ice for 3 h, and the solubilized material was clarified by centrifugation at 100,000 X g for 
1 h. 
The supernatant was incubated for 10 min at 37°C to induce phase separation (1), and after 
low-speed centrifugation (2500 rpm) for 10 min at room temperature, the upper water-phase 
and lower detergent-phase were collected. The water-phase was extracted once more with 2% 
(final concentration) Triton X-l 14, and the combined detergent-phases were stored at -70oC. 
2. Imrauno-alTinity chromatography. An immuno-affinity column was prepared by coupling 
20 mg mab-IgG 32F5 (10) to 20 ml of freshly prepared CNBr-activated CL-Sepharose 
(kindly provided by Dr. A. N.Vermeulen, Intervet, Boxmeer, The Netherlands). Five ml of 
this material were incubated batchwise with the detergent-phase, which was diluted to a 
volume of 60 ml with 10 x binding buffer. Final concentrations were 30 mM Tris-HCl (pH 
7.5), 500 mM NaCl, 7% Triton X-114, and the above protease inhibitors. Incubation was 
performed at 4 0C overnight on an overhead rotator. The gel was washed twice with 50 ml 
of 50 mM Tris-HCl (pH 8.2), 500 mM NaCl, 1 mM EDTA, 0.5% NP-40, twice with 50 ml 
of 50 mM Tris-HCl (pH 8.2), 150 mM NaCl, 0.5% NP-40, 0.1% SDS, and twice with 50 
ml of 150 mM NaCl. All washing buffers contained the above protease inhibitors. The gel 
was finally washed with 50 ml of twice distilled water, and bound proteins were eluted by 
incubating the gel for 10 min with 5 ml 1% SDS (w/v) in water at 70oC. The gel was 
washed once with 5 ml of water, and the combined fractions were lyophilized. 
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3. Sodium dodecyl sulfate-polyacrylamidegelelectrophoresis. Thelyophilized material was 
solubilized by boiling for 10 min in 400 μΐ 125 mM Tris-HCL (pH 6.8). Glycerol and 
bromophenol blue were added to final concentrations of 10% and 0.005%, respectively, and 
the solution was loaded into six slots of a 10% porous SDS-polyacrylamide gel as described 
by Plaxton and Moorhead (6). After electrophoresis, the gel was stained with Coomassie 
brilliant blue for 30-45 min, and destained for 1 h in 7.5% methanol, 7.5% acetic acid. 
Protein amounts were estimated after staining by comparing band-intensity with the intensity 
of marker proteins. The polypeptide bands of 45-kDa and 48-kDa were excised from the gel 
and stored in eppendorf tubes at -20eC. 
Trypsin digestion and high-performance liquid chromatography separation of tryptic 
peptides 
Digestion and separation procedures were tested and optimized using Sendai virus Fl 
protein as a model protein. Trypsin digestion was essentially according to Minotti et al. (5). 
Three gel slices containing 45-kDa or 48-kDa (total amount of 45-kDa approximately 12 μg 
and of 48-kDa roughly 9 ¿ig) were equilibrated in 100 mM sodium-borate (pH 9.0), at 370C 
for 1 h. The slices were then homogenized in minisorp-tubes (Nunc, Roskilde, Denmark) 
using a glass rod, in 400 μΐ borate buffer, containing 1 μg/ml sequence grade trypsin 
(Boehringer, Mannheim, BRD). Digestion was performed at 370C, and additional amounts 
of trypsin (1 μg/ml) were added after 24 h and 60 h incubation. Digestion was stopped after 
72 h by freezing the suspension and storing it at -20oC. 
The resultant tryptic peptides were separated on a Beekman HPLC system (System Gold, 
Beekman Instruments Inc., San Ramon, CA, U.S.A.), equipped with a 4.7 x 250-mm C-18 
reversed-phase column (Ultrasphere ODS, Beekman). The liquid containing the tryptic 
peptides was separated from the Polyacrylamide suspension, which was washed once with 
100 μΐ of water. Dithiotreitol (OTT) was added to a final concentration of 10 mM, and after 
incubation at 370C for 30 min, the solution was applied to the column. Peptides were eluted 
using the following conditions: Mobile phase: A= 0.063% trifluoroacetic acid (TFA) in 
water; B= 0.06% TFA in acetonitril-water (80:20); gradient conditions: 0-40% В in 60 min, 
40-75% В in 30 min, 75-100% В in 10 min, 1 ml/min. The absorbance was monitored at 
214 nm and fractions were collected by hand in eppendorf tubes. Suitable fractions were 
dried in a Speed Vac centrifuge (Savant Instruments, Hicksville, NY, U.S.A.) and sent for 
sequence analysis on a gas-phase sequanator (Eurosequence BV, Groningen, The 
Netherlands). 
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SDS-PAGE and Immunoblotting 
Samples were subjected to non-reducing SDS-PAGE using the Bio-Rad Mini-Protean 
II apparatus and the discontinuous system of Doucet and Trifaro (2). Acrylamide monomer 
concentration in the 15-sample well, 0.75-mm-thick slab gels, was 4% for the stacking gel 
and 10% for the running gel. Samples (0.5-1 x 106 gametocyte equivalents) were incubated 
in the presence of SDS sample buffer (125 mM Tris-HCL (pH 6.8), 2% SDS, 0.005% 
bromophenol blue) for 10 min at 100oC, prior to being loaded on the gel. Alternatively, 
Coomassie-stained, excised, polypeptide containing gel slices were equilibrated in SDS 
sample buffer for 30 min at 37°C with three changes of buffer. The slices were loaded into 
slots of a 10-sample well, 1.5-mm-thickslab gel, and overlayered with SDS sample buffer. 
Gels were electrophoresed at a constant voltage of 150 V applied until the tracking dye had 
reached the bottom of the gel. Gels were either stained with Coomassie brilliant blue, 
silverstained according to Wray et al. (13), or electroblotted onto polyvinylidenedifluoride 
(PVDF) membranes (Immobilon-P, Millipore Corp., Bedford.MA, U.S.A.) using the Bio-
Rad Mini-Protean II blotting apparatus in a buffer consisting of 50 mM Tris, 50 mM borate, 
15% methanol. Blots were blocked with 3% BSA in phosphate-buffered saline supplemented 
with 0.1 % Tween-20 (PBST) for 1 h at room temperature. Then the blots were incubated for 
1 h at room temperature with mab 32F5 (10 /ig/ml in PBST), and finally for 1 h at room 
temperature with rabbit anti-mouse IgG conjugated to alkaline phosphatase (RAM-AP, 
1:8,000 in PBST, Zymed, San Francisco, CA, U.S.A.). Color was developed in the presence 
of 0.05 mg/ml 5-bromo-4-chloro-3-indolylphosphatep-toluidine salt (BCIP, Sigma) and 0.05 
mg/ml nitro blue tetrazolium (NBT, Merck, Darmstadt, BRD). 
RESULTS 
Purification of the 45/48-kDa protein 
Since the 45/48-kDa protein is a hydrophobic membrane protein, we used a Triton 
X-114 extraction followed by phase-separation as a first step in the purification of the 
protein. The detergent is necessary to solubilize the membrane proteins and, after phase-
separation, the hydrophobic proteins are present in the detergent phase, while water-soluble 
proteins are present in the water phase (1). Immunoblotting using mab 32F5 to trace the 
45/48-kDa protein showed, that the protein is present in the detergent phase and not in the 
water phase. The insoluble pellet, obtained after high-speed centrifugation of the extracted 
gametocytes, showed to contain only traces of the 45/48-kDa protein. Sonication of the 
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Figure 1. SDS-PAGE of eluate from immuno-affimty 
column, using Mab 32F5 covalently coupled to 
sepharose. The immuno-affuuty matrix, prepared as 
desenbed in Materials and Methods, was incubated 
batch-wise with a detergent extract of 3 x IO9 
gametocytes. After washing, bound proteins were eluted 
with 1% SDS at 70oC. The eluate was lyophihzed, 
solubihzed in 12S mM Tns-HCL, pH 6.8, and 
subjected to SDS-PAGE on a 10% gel. One of 6 
identical lanes is shown after Coomassie-staimng. 
Arrows indicate the 45-kDa and 48-kDa polypeptide 
bands. To the nght, relative molecular masses of 
reference proteins are shown in kDa. 
gametocytes appears to be essential for a satisfactory extraction. 
The second step in the purification was immuno-affinity chromatography. We coupled 
mab 32FS directly to freshly activated Sepharose, since this method yielded a column which 
only leaked very small amounts of IgG during elution of the 45/48-kDa protein. The use of 
a column prepared by crosslinking 32F5 to protein A-Sepharose resulted in much more IgG 
in the final eluate, even more than the 45/48-kDa protein itself. Elution with 1 % SDS at 
70°C was convenient, since a final purification step using an SDS gel was necessary. 
Immunoblotting of eluted material and residual sepharose material showed that virtually all 
the 45/48-kDa protein eluted from the 32F5-sepharose using this protocol. 
The final step in the purification was SDS-PAGE. In Figure 1, one lane of the gel is 
shown after staining. The most prominent bands are 45-kDa and 48-kDa, 48-kDa being 
present in slightly lower amounts than 45-kDa. Total amounts of 45-kDa and 48-kDa protein, 
isolated from 3 x 10' gametocytes, were estimated to be about 24 ¿¿g and 18 μg, 
respectively. Contaminating polypeptide bands of 25-kDa, 43-kDa and 160-kDa are also 
present. These polypeptide bands are probably the light chain and the heavy chain of IgG and 
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Figure 2. HPLC profiles of tryptic digests of 45-kDa (top) and 48-kDa (bottom). Tryptic digests of 45-kDa and 
48-kDa were prepared as described ш Materials and Methods, and the resultant peptides were separated by reversed-
phaseHPLC. Mobile phase: A= 0.063% TFA ш water, B= 0.06% TFA m acetonitnl-water (80:20); gradient 
conditions: 0-40% В in 60 nun, 40-75% В in 30 mm, 75-100% В ш 10 nun, 1 ml/nun. Peaks were collected 
by hand and numbered peaks were dned and used for sequence analysis. 
intact IgG, respectively. On an immmunoblot, 25-kDa and 43-kDa reacted with rabbit-anti-
mouse IgG, indicating that these polypeptide bands are indeed IgG components. The 45-kDa 
and 48-kDa polypeptide bands were excised from the gel and electro-elution into a second 
gel, followed by immunoblotting showed little cross contamination of the two proteins. In 
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addition, neither of the excised polypeptide bands reacted with rabbit-anti-mouse IgG, 
indicating that there was no detectable contamination with IgG products. The porous gel used 
in this experiment has several advantages over conventional SDS gels (4). Firstly, the gels 
have an excellent resolution, making it possible to separate the 45-kDa and 48-kDa proteins, 
using a fairly low Polyacrylamide percentage. Secondly, the porous nature of the gel makes 
it easy to electro-elute polypeptide bands into a second gel. Furthermore, the high porosity 
facilitates the tryptic digestion process, making the polypeptide bands easily accessible for 
trypsin. 
Isolation and sequence analysis of tryptic peptides 
Trypsin digestion of the protein in a gel slice appeared to be complete after 72 h of 
digestion, since after this time no changes in the HPLC profile of the tryptic peptides were 
observed. (Only minor changes were observed after 24 h of incubation). It was also 
determined that at least 6 pg of protein in gel slices had to be present to detect peaks during 
HPLC separation at 0.1 absorbance units full scale (AUFS). In Figure 2 the HPLC profiles 
of the digests of the 45-kDa and 48-kDa protein are shown. The gradient was started after 
the DTT peaks were eluted from the column. It is apparent that there are no large differences 
between the tryptic maps of both proteins, suggesting that the 45-kDa and 48-kDa proteins 
are essentially identical. Numbered peaks were dried and used for sequence analysis. (The 
selection of these peaks was based on the absence of these peaks in the trypsin blank.) Since 
the 48-kDa protein was present in lower amounts than the 45-kDa protein, only 1 peak from 
the HPLC profile of the 48-kDa protein was used for sequence analysis. The results of the 
sequence analyses are shown in Table 1. Four of the 9 analysed peaks (peaks 1, 2, 6 and 8) 
contained enough material to yield a reliable amino acid sequence. From the other 5 peaks 
no reliable sequence information was obtained. Furthermore, the sequence obtained from the 
peptide in peak 6 was identical to that from peak 2, and the sequence from peak 2 partially 
overlapped with the sequence obtained from the peptide in peak 1. 
DISCUSSION 
In this study we describe the isolation, purification and tryptic digestion of the 45/48-
kDa surface protein of P.falciparum gametocytes. The purified 45/48-kDa protein was 
subjected to tryptic digestion in order to create N-termini suitable for sequence analysis, since 
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Table 1. Gas-phase sequence analysis of tryptic peptides of the 45- and 48-kDa protein from P.falcipanm. 
Peak" 
Cycle 
1 
2 
3 
4 
5 
6 
7 
8 
9 
1 0 
1 1 
1 2 
1 3 
1 4 
1 5 
1 6 
E 
Τ 
( 
I 
S 
ε 
L 
G 
L 
I 
E 
Y 
E 
I 
E 
1 
( ν , Ρ ) " 
( 9 . 8 ) = 
( 1 9 . 1 ) 
W,D,C) 
( 1 6 . 9 ) 
( 1 5 . 7 ) 
( 9 . 5 ) 
( 1 3 . 0 ) 
( 1 6 . 8 ) 
( 1 3 . 3 ) 
( 1 1 . 5 ) 
( 5 . 6 ) 
( 6 . 7 ) 
( 6 . 7 ) 
( 7 . 3 ) 
( 5 . 8 ) 
2 
(V,S) 
Y ( 9 . 4 ) 
Τ ( 1 7 . 9 ) 
( I ) ( 1 3 . 1 ) 
Y ( 1 3 . 7 ) 
E ( 1 3 . 2 ) 
Ν ( 1 3 . 7 ) 
_d 
(vHio. i ) 
E ( 1 0 . 7 ) 
Τ ( 9 . 8 ) 
(D) ( 8 . 9 ) 
I ( 6 . 9 ) 
S ( 9 . 1 ) 
E ( 5 . 2 ) 
L ( 6 . 4 ) 
3 4 
_i _ 
(Η,Μ,Ε) 
- ( Ν ) ( 1 . 8 ) 
- ( E ) ( 0 . 8 ) 
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-
* peak from HPLC profile 
ь
 amino acid (one letter codons) between brackets are tentative assignments 
' pmoles PTH-amino acid identified 
<l
 no ammo acid identified. 
it was assumed that a blocked N-terminus might direct sequence analysis, as was shown for 
the 25-kDa protein (3; Fries unpublished results). 
The isolation of the 45/48-kDa protein from gametocytes was essentially the same as 
the isolation of the 25-kDa protein from gametes (Chapter 5). An important difference is the 
amount of starting material, roughly six times more than that used for the isolation of the 25-
kDa protein, so the isolation procedure could be followed on SDS-PAGE and by Coomassie 
brilliant blue staining. Furthermore, the use of freshly prepared CNBr-activated sepharose 
to couple mab-IgG instead of cross-linking mab-IgG to protein-A sepharose or using 
commercial available CNBr-activated sepharose was an important improvement in the 
procedure. In previous experiments, where mab-IgG was coupled to protein-Α sepharose, a 
relatively large amount of IgG co-eluted with the 45-kDa and 48-kDa protein. The IgG-
component could not be separated from the 45-kDa protein on SDS-PAGE. After the tryptic 
digestion, peptides available in the picomole range were subjected to microsequence analysis 
and turned out to give IgG sequences. So, the interference was only observed after 
microsequencing analysis. Therefore, several sepharoses were tested and leakage of IgG was 
inevitable, but appeared to be least when mab-IgG was coupled to freshly prepared CNBr-
activated sepharose. 
After elution of the 45/48-kDa protein from the immuno-affintiy column with 1 % 
SDS, the protein could be separated on a porous SDS-PAA gel from the leaking IgG protein. 
The 45-kDa protein could also be separated from the 48-kDa protein on this porous SDS-gel, 
and this separation provides an opportunity to obtain more information about the similarity 
of these proteins on basis of their individual HPLC-pattems after tryptic digestion. 
The digestion of the 45/48-kDa protein with trypsine was optimized using Fl protein of 
Sendai virus as a model protein. This protein was used since it resembles the 45/48-kDa 
protein very closely in several ways: Fl is a very hydrophobic, glycosylated membrane 
protein of about 50-kDa. Furthermore, it contains cysteine residues, which are also present 
in 45/48-kDa. Advantages are that Fl is easily obtained in relatively large amounts after 
HPLC separation of detergent extracts of purified Sendai virus (12), or after SDS-PAGE, and 
that the amino acid sequence of the protein is known (9). 
It is obvious that the HPLC-pattems of the tryptic digests of the 45-kDa protein and the 48-
kDa protein are essentially identical, indicating that the 45-kDa protein and the 48-kDa 
protein are highly homologous or identical polypeptide chains. Since the 45-kDa and 48-kDa 
protein possess the same isoelectric point, both 6.0 ± 0 . 1 (11), the protein must contain 
non-charged groups, probably posttranslational modifications, which are responsible for the 
different mobilities on SDS-PAGE. 
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Sequence analysis of peptides which eluted in the peaks 1, 2 and 6 (Fig. 2, Table 1) 
indicated that the tryptic digestion of the 45-kDa and 48-kDa protein was partial. Sequence 
analysis of the peptides eluted in peak 1 and 2 showed an overlapping sequence and the 
sequence analysis of the peptide eluted in peak 6 showed an identical sequence as found for 
the peptide eluted in peak 2. Possible explanations for the overlapping sequences may be a 
partial tryptic digestion of the protein or the presence of repeating sequences in the protein. 
Since the peptides used for the sequence analysis were from different regions of the HPLC-
pattem (Fig. 2), the most likely explanation seems to be a partial tryptic digestion. 
Furthermore, if the non-identified amino acid in the peptide eluted in peak 2 (position 8) 
shows to be a lysine or arginine, this would provide more evidence for a partial digestion. 
Oligonucleotide probes have been made from the sequences obtained from peptides 
eluted in peak 2 (positions 2-7) and eluted in peak 8 (positions 1-5). With these probes 
P.falciparum genomic- and cDNA-libranes in E.coli are being screened in order to select the 
gene coding for the 45/48-kDa protein. These are the first steps towards the elucidation of 
the primary structure of the 45-kDa and 48-kDa protein of P.falciparum, an important target 
protein for transmission blocking antibodies. 
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SUMMARY AND PERSPECTIVES 
Malaria vaccines are being developed against different stages in the parasite life 
cycle, each with the objective of developing additional methods for the control of malaria. 
Sporozoite vaccines should prevent the transmission of parasites from mosquito to man, 
while merozoite vaccines should diminish the pathology caused by the asexual 
erythrocytic stages of the parasite. The first recombinant DNA and synthetic peptide 
sporozoite and merozoite vaccines have been tested in humans, however with only partial 
success. A sexual stage vaccine is also an opportunity to control malaria. This vaccine 
would prevent the development of the parasitic stages in the female anopheline mosquito 
when these mosquitoes take a bloodmeal containing sexual stage parasites. This vaccine is 
not directly protective against the disease in man but should control malaria at a 
population level. 
The development of a sexual stage vaccine has to pass through many phases. The 
first phase is to obtain knowledge on the biochemistry and immunology of the malaria 
sexual stage parasites. Much basic knowledge about the sexual stage parasites, and 
especially on the target antigens of transmission blocking antibodies has been collected 
during the last 10 to 15 years (Chapter 1). 
In this thesis two antigens synthesized and expressed in gametocytes, gametes or 
ookinetes of Plasmodium falciparum were the subjects to detailed investigations. These 
antigens, with a molecular weight of 45/48-kDa and 25-kDa, are two important targets of 
transmission blocking antibodies, and therefore potential candidates for a transmission 
blocking vaccine. 
The synthesis of the 25-kDa protein in the midgut stages (gametes, zygotes and 
ookinetes) of Plasmodium falciparum was studied using metabolic inhibitors (colchicine 
and actinomycin D) and pulse-labeling experiments (Chapter 2). Experiments with 
colchicine showed that, immediately after induction of macrogametogenesis, 25-kDa 
protein synthesis occurs in both fertilized and non-fertilized macrogametes. The amount 
of 25-kDa protein synthesized increased slowly with time. Experiments with actinomycin 
D indicated that the slow increase of synthesis may be dependent on de novo messenger 
RNA synthesis. 
Knowledge about the contribution of the tertiary structure and the post-translational 
modifications (glycosylation and acylation) to the structure of the epitopes on the target 
antigens of transmission blocking antibodies is important with respect to the development 
of vaccine based on recombinant DNA or synthetic peptide technology. Modification of 
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the three-dimensional structure and modification or cleavage of the carbohydrate groups 
and fatty acids linked to the protein were performed in order to investigate their effects 
on the immunological reactivity of the epitopes with the transmission blocking antibodies 
(Chapter 3 and 4). The immunological reactivity of the modified protein was established 
by three different techniques: (1) immunoprecipitation of radiolabelled proteins, (2) 
enzyme-linked- immunosorbent assay (ELISA) and (3) Westem-blotting (Chapter 3). The 
25-kDa protein is post-translationally modified by carbohydrate groups and by fatty acids. 
The results of the experiments indicate that the immunological reactivity of the major 
epitopes on the 25-kDa protein, including the epitope involved in transmission-blocking 
immunity, are dependent on the tertiary structure of the protein and on the presence of 
linked fatty acids, but not on the presence or absence of carbohydrate groups. 
The 45-kDa and 48-kDa protein is post-translationally modified by carbohydrate 
groups and not by acyl groups. The contribution of the carbohydrate groups to the 
expression of the epitopes, including the epitope involved in transmission blocking 
immunity, could not be established by modifying or cleaving these groups. The inability 
to obtain clear evidence was caused by insufficient quantities of available protein. 
Furthermore the 45-kDa and 48-kDa protein seemed to be unstable during prolonged 
storage and lasting experiments (Chapter 4). 
In order to clone the genes, encoding the 25-kDa, the 45-kDa and 48-kDa protein 
of P.falciparum, immunological probes were used to screen P.falciparum genomic- and 
cDNA-libraries in E.coli. However, due to the conformational character of the epitopes, 
these attempts were not succesful. Therefore, it was necessary to isolate and purify the 
25-kDa protein (Chapter 5) and the 45-kDa and 48-kDa protein (Chapter 6). The results 
obtained with the isolation and purification of the 25-kDa protein have been applied in the 
development of an isolation procedure of the 45-kDa and 48-kDa protein. 
The N-terminus of the 25-kDa protein turned out to be blocked, preventing direct amino 
acid sequencing, and enzymatic digestion was necessary to obtain peptides with free N-
termini for sequence analysis. Since the N-terminus of th 45-kDa and 48-kDa protein is 
most likely also blocked, enzymatic digestion of the purified 45-kDa and 48-kDa protein 
was also used to generate internal peptides of these proteins with free N-terminal ends. 
The gene coding for the 25-kDa protein has been sequenced by Kaslow et al. and the 
amino acid sequence of this protein cold be derived. For the 45-kDa and 48-kDa protein, 
tryptic peptides have been sequenced successfully; the resulting amino acid sequences are 
being used to design oligonucleotide probes for the screening of P.falciparum genomic-
and cDNA-libraries in E.coli. 
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PERSPECTIVES 
Perspectives for a sexual stage component in a multivalent malaria vaccine that is 
composed of antigens of variuos developmental stage of the parasite can be summarized 
as follows. Further progress towards the development of a multivalent malaria vaccine 
with a 25-kDa protein component became likely possible after cloning the gene encoding 
this protein. The posttranslational modifications of the 25-kDa protein, and especially its 
dependence on the natural tertiary structure for the maintenance of its natural antigenicity, 
however are causing problems with the production of the 25-kDa immunogen. 
Immunization experiments with various synthetic peptides (based on amino acid sequences 
obtained in an Pepscan, and selected by transmission blocking antibodies; Beckers, 
personal communication) remained unsuccesful. Also products of various DNA expression 
systems did not succesfully induce the production of transmission-blocking antibodies 
(Koeken, personal communication). These results indicate how important it is to 
determine the three-dimensional structure of this protein and to identify the linked fatty 
acids and the nature of the linkages involved. Such information might contribute the 
understanding of how anti 25-kDa transmission blocking antibodies effectively interfere in 
the sporogonie development of the malaria parasite. 
Besides the other, already known target antigens (45-kDa, 48-kDa and 230-kDa) 
of transmission blocking antibodies, the search for other potential candidates remains 
important in the development of an effective sexual component in a multivalent malaria 
vaccine. 
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SAMENVATTING 
De ziekte malaria wordt veroorzaakt door een eencellige parasiet van het genus 
Plasmodium. Van dit genus zijn vier soorten bekend, die de mens kunnen infecteren. 
Deze parasieten worden overgedragen via een muskiet. Malaria is in tropische gebieden 
een enorm probleem voor de volksgezondheid, vooral na de steeds groeiende resistentie 
van de mug tegen insecticiden en van de parasiet tegen anti-malaria middelen. 
Een malaria vaccin, vooral gericht tegen de verwekker van de voor de mens dodelijke 
malaria parasiet Plasmodium falciparum, is van groot belang om de ziekte malaria en de 
transmissie van de parasiet van de mug naar de mens (en omgekeerd) terug te kunnen 
dringen. Door de huidige ontwikkelingen in de immunologie en biotechnologie behoort de 
ontwikkeling van een malaria vaccin tot de mogelijkheden. 
Door de levenscyclus van de parasiet te doorbreken kan de ziekte en de 
transmissie van de parasiet worden tegengegaan. De parasiet ondergaat echter gedurende 
de ontwikkeling in de vector (de mug) en in de gastheer (de mens) een aantal ingrijpende 
veranderingen. De verschillende stadia die in de levenscyclus van de parasiet worden 
onderscheiden, zijn: de asexuele stadia (waaronder de sporozoïeten en merozoïeten) en de 
sexuele stadia (waaronder gametocyten, gameten, zygoten en ookineten). Tegen deze 
verschillende stadia worden malaria vaccins ontwikkeld. Vaccins gericht tegen de 
sporozoïeten moeten de transmissie van de parasiet van muskiet naar de mens voorkomen, 
terwijl vaccins gericht tegen merozoïeten, de ziekte in de mens moeten voorkomen en 
afzwakken. De eerste vaccins, gericht tegen deze twee stadia, zijn gemaakt met behulp 
van recombinant-DNA technieken en met synthetische peptiden. De eerste vaccinaties, 
uitgevoerd in mensen, waren echter slechts gedeeltelijk succesvol. 
Een vaccin gericht tegen de sexuele stadia is ook een mogelijkheid om de 
levenscyclus te doorbreken, en met name de transmissie van de mens naar de muskiet te 
verhinderen of te blokkeren. Dit 'transmissie blokkerende' vaccin is geen vaccin dat 
direct bescherming biedt tegen de ziekte in de mens, maar het kan de verspreiding van 
malaria in een bepaald gebied terug dringen. 
In de afgelopen 10 tot IS jaar is veel biochemisch en immunologisch onderzoek 
gedaan aan de sexuele stadia van de parasiet en aan de eiwitten die specifiek op de 
buitenkant van gametocyten, gameten en ookineten aanwezig zijn. Immunisatie met intacte 
gametocyten en/of gameten induceerde een transmissie blokkerende immuniteit, waarbij 
de transmissie blokkerende antilichamen voornamelijk gericht zijn tegen de eiwitten die 
zich op het oppervlak van de sexuele stadia bevinden. Het in dit proefschrift beschreven 
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onderzoek gaat over twee van deze eiwitten (antigenen) die in de gametocyten, gameten 
en ookineten van Plasmodium falciparum gesynthetiseerd worden en op het oppervlak van 
deze stadia geëxposeerd worden. Deze eiwitten, met een molekuulgewicht van 45/48-
kiloDalton (kDa) en 25-kDa, zijn twee belangrijke antigenen waartegen transmissie 
blokkerende antilichamen gericht zijn, en daarom potentiële kandidaten voor een 
transmissie blokkerend vaccin. 
De synthese van het 25-kDa eiwit in de macrogameten, Zygoten en ookineten van 
Plasmodium falciparum werd bestudeerd met behulp van colchicine en actinomycine D 
(stoffen die specifieke processen in de parasiet remmen) en met 'pulse-labeling' 
experimenten (Hoofdstuk 2). De experimenten met colchicine laten zien dat het 25-kDa 
eiwit onmiddellijk na de inductie van de macrogametogenese gesynthetiseerd wordt, in 
zowel bevruchte als niet-bevruchte macrogameten. De hoeveelheid gesynthetiseerd 25-kDa 
eiwit is niet direct heel hoog, maar neemt langzaam in de tijd toe. Experimenten met 
actinomycine D wezen uit dat de synthese van het 25-kDa eiwit afhankelijk is van de de 
novo boodschapper-RNA synthese. Dit is een mogelijke verklaring voor de langzame 
toename in de hoeveelheid gesynthetiseerd 25-kDa eiwit gedurende de tijd. 
De structuur van de epitopen op de antigenen van Plasmodium falciparum, 
waartegen ondermeer de transmissie blokkerende antilichamen gericht zijn, kan mede 
bepaald worden door de drie-dimensionale structuur van het eiwit en door de 
posttranslationele modificaties (bv. aanhechting van suikergroepen of vetzuurketens) van 
het antigeen. De mate waarin een bijdrage wordt geleverd door deze posttranslationele 
modificaties aan de structuur van de epitopen is van groot belang voor de ontwikkeling 
van een vaccin gebaseerd op recombinant-DNA of synthetische peptiden technologie. 
De immunologische reactiviteit van de epitopen, met name die epitopen die de transmissie 
blokkerende antilichamen herkennen, kan worden bestudeerd door de drie-dimensionale 
structuur te veranderen en door de posttranslationele modificaties te veranderen en/of te 
niet te doen (Hoofdstuk 2 en 3). De immunologische reactiviteit van het gemodificeerde 
eiwit werd met behulp van drie verschillende technieken vastgesteld: (1) immuno-
precipitatie van radioactief gelabelde eiwitten; (2) een enzym gebonden immuno-absorptie 
test (ELISA) en (3) Western Blotting. 
Het 25-kDa eiwit is posttranslationeel gemodificeerd door aanhechting van 
suikergroepen en vetzuurketens. De resultaten van de experimenten geven aan dat de 
immunologische reactiviteit van de belangrijkste epitopen op het 25-kDa eiwit, waaronder 
het epitoop dat herkend wordt door transmissie blokkerende antilichamen, afhankelijk is 
van de natuurlijke drie-dimensionale structuur van het eiwit en van de aanwezigheid van 
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vetzuurketens. De suikergroepen dragen niet bij aan de immunologische reactiviteit van de 
epitopen (Hoofdstuk 3). 
In tegenstelling tot het 25-kDa eiwit bevat het 45/48-kDa eiwit geen vetzuurketens, 
maar wel suikergroepen. Of deze suikergroepen een bijdrage leveren aan de structuur van 
de epitopen kon niet worden vastgesteld. Het was namelijk niet mogelijk om eenduidig de 
immunologische reactiviteit te bepalen door onvoldoende eiwit. Verder bleek het 45/48-
kDa eiwit gedurende de opslag van het eiwit en gedurende de experimenten instabiel te 
zijn (Hoofdstuk 4). 
Pogingen om de genen, die coderen voor het 25-kDa eiwit en het 45/48-kDa eiwit 
van Plasmodium falciparum, te identificeren met behulp van immunologische 'probes' 
(antilichamen) waren niet succesvol. De voornaamste reden was de conformationele 
structuur van de epitopen. Opheldering van de aminozuurvolgorde van het 25- en het 
45/48-kDa eiwit werd daarom noodzakelijk en daarmee ook de isolatie en zuivering van 
deze eiwitten. De resultaten die verkregen zijn bij de isolatie en zuivering van het 25-kDa 
eiwit zijn gebruikt om een isolatie procedure voor het 45/48-kDa eiwit te ontwikkelen 
(Hoofdstuk 5 en 6). 
Door directe aminozuurvolgorde bepaling van het 25-kDa eiwit bleek het N-
uiteinde geblokkeerd te zijn. Een enzymatische splitsing van het eiwit was nodig, om 
peptiden met een vrij N-uiteinde te genereren. Omdat het N-uiteinde van het 45/48-kDa 
eiwit waarschijnlijk ook geblokkeerd zou zijn en dus niet geschikt voor directe 
aminozuurvolgorde bepaling, werden van het 45/48-kDa eiwit al tijdens de isolatie 
procedure, met behulp van een enzymatische splitsing, peptiden met een vrij N-uiteinde 
gegenereerd. 
De basevolgorde van het gen dat codeert voor het 25-kDa eiwit kon worden bepaald door 
Kaslow et al., nadat van een aantal peptiden, verkregen door enzymatische splitsing met 
trypsine, de aminozuurvolgorde was vastgesteld. De aminozuurvolgorde van het hele 25-
kDa eiwit kon daarna worden afgeleid van de basevolgorde van het gen. 
Van het 45/48-kDa eiwit is van een aantal peptiden, verkregen door enzymatische 
splitsing met trypsine, de aminozuurvolgorde vastgesteld. Van deze aminozuurvolgordes 
kunnen oligonucleotide 'probes' gemaakt worden, waarmee het gen, dat codeert voor het 
45/48-kDa eiwit, geïdentificeerd en geïsoleerd kan worden. 
Ondanks het feit dat het onderzoek aan de sexuele stadia van de malaria parasiet 
moeizaam verloopt behoort de ontwikkeling van een transmissie blokkerend malaria 
vaccin zeker tot de mogelijkheden. Een efficiënt vaccin zal echter gevormd moeten 
worden uit meerdere componenten, gericht tegen alle stadia van de levenscyclus van de 
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parasiet. Hoewel gestaag vorderingen worden geboekt in de ontwikkeling van zo'n vaccin, 
zal de preventie en bestrijding van malaria in de komende jaren nog met de bestaande 
middelen moeten worden uitgevoerd. 
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STELLINGEN 
1. Wanneer monoklonale antilichamen worden gebruikt om DNA-bibliotheken in 
Escherichia coli te screenen is het van belang om vooraf te weten of de monoklonale 
antilichamen tegen een continue of discontinue aminozuurvolgorde zijn gericht. 
2. Door alleen standaardtechnieken toe te passen zuiver je nog geen eiwit. 
3. Met behulp van computer-simulaties en op basis van gelijkenissen met andere eiwitten 
kan inzicht in de structuur worden verkregen, maar die structuur kan hiermee niet 
bepaald worden. 
4. De toepassing van 'polymerase chain reaction' verhoogt weliswaar de gevoeligheid 
van parasiet detectie in patientenmateriaal, maar het het maakt het noodzakelijk om 
kwantitatieve criteria vast te stellen in het geval van opportunistische infecties als 
pneumocystose. 
Wakefield A. E. et al. (1990) Lancet 336, 451-453. 
5. Bruin brood, daar zit wat in. 
Eijkman С (1917) Ned. Tijdschr. Geneeskd. 17, 1352-1358. 
6. De technische vooruitgang verschaft ons meer mogelijkheden, echter niet die 
mogelijkheden die de nood in de wereld kunnen lenigen. 
7. Vrouwen die een carrière ambiëren, dienen gemotiveerder te zijn dan mannen in 
vergelijkbare posities. 
8. De extra ontplooiingsmogelijkheden die kinderen in een kinderdagverblijf geboden 
worden, maken dat je met een gerust hart 'dag' tegen je kinderen kunt zeggen. 
9. Als je van een mug een olifant kon maken, zou dat het onderzoek naar de malaria 
parasiet sterk vereenvoudigen. 
10. 1 + 1 = 2, echter 1-ling + 1-ling ?£ 2-ling. 
Hella Fries 
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